cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AA248618 | .a | 777 to 908 | 22 to 154 | 133/162 (82 %) | 7 diff (95.7 %id) | ||||
AA311266 | heart | .a | 710 to 999 | 1 to 291 | 291/296 (98 %) | 2 diff (99.4 %id) | |||
BP195541 | brain | .a | 670 to 1252 | 1 to 583 | 583/583 (100 %) | 0 diff (100 %id) | |||
BP196775 | adrenal gland | .a | 685 to 1265 | 1 to 581 | 581/581 (100 %) | 0 diff (100 %id) | |||
BP197194 | adrenal gland | .c | 99 to 680 | 1 to 582 | 582/582 (100 %) | 2 diff (99.7 %id) | |||
BP198273 | adrenal gland | .a | 651 to 1231 | 1 to 581 | 581/581 (100 %) | 0 diff (100 %id) | |||
DA015861 | adrenal gland | .a | 651 to 1208 | 2 to 559 | capped | 558/558 (100 %) | 0 diff (100 %id) | ||
AJ707106 | heart | .a | 830 to 1354 | 524 to 1 | Submitted on the opposite strand | 524/524 (100 %) | 4 diff (99.3 %id) | ||
AJ709809 | heart | .a | 930 to 1426 | 497 to 1 | Submitted on the opposite strand | 497/497 (100 %) | 2 diff (99.6 %id) | ||
AJ711111 | heart | .a | 1026 to 1438 | 429 to 17 | Submitted on the opposite strand | 413/429 (96 %) | 0 diff (100 %id) | ||
AK302338 | testis | .c | 238 to 1214 | 1 to 977 | exact | 977/977 (100 %) | 0 diff (100 %id) | ||
AK308562 | cerebellum | .b | 615 to 1459 | 1 to 846 | K16Q | tiling clone, | 846/846 (100 %) | 2 diff (99.8 %id) | |
AK312645 | .a | 649 to 1272 | 1 to 624 | exact | 624/624 (100 %) | 0 diff (100 %id) | |||
AK315994 | brain | .c | 95 to 976 | 1 to 882 | E11G | tiling clone, | 882/882 (100 %) | 2 diff (99.8 %id) | |
AW362990 | colon | .h-u | 1339 to 1720 | 1 to 381 | tiling clone, | 381/381 (100 %) | 12 diff (96.9 %id) | ||
AW603515 | colon_normal | .h-u | 1134 to 1408 | 272 to 1 | 272/288 (94 %) | 8 diff (97.3 %id) | |||
AW800872 | uterus | .h-u | 1351 to 1621 | 13 to 284 | 272/300 (90 %) | 8 diff (97.4 %id) | |||
AW800934 | uterus | .h-u | 1365 to 1593 | 235 to 4 | 232/255 (90 %) | 0 diff (100 %id) | |||
AW800952 | uterus | .h-u | 1353 to 1621 | 1 to 268 | 268/297 (90 %) | 7 diff (97.7 %id) | |||
AW801027 | uterus | .h-u | 1370 to 1600 | 13 to 243 | 231/243 (95 %) | 6 diff (97.6 %id) | |||
AW801058 | uterus | .h-u | 1365 to 1621 | 10 to 264 | 255/290 (87 %) | 3 diff (99.0 %id) | |||
AW801063 | uterus | .h-u | 1365 to 1626 | 10 to 270 | 261/274 (95 %) | 6 diff (97.9 %id) | |||
AW801065 | uterus | .h-u | 1357 to 1621 | 1 to 264 | 264/281 (93 %) | 6 diff (97.9 %id) | |||
AW801724 | uterus | .a | 1811 to 2200 | 397 to 9 | 389/397 (97 %) | 0 diff (100 %id) | |||
AW811837 | stomach | .j-u | 42 to 259 | 1 to 219 | 219/219 (100 %) | 3 diff (98.7 %id) | |||
AW885498 | ovary | .h-u | 1365 to 1621 | 317 to 61 | 257/326 (78 %) | 0 diff (100 %id) | |||
AW976013 | .h-u | 473 to 1048 | 702 to 129 | C22* | Submitted on the opposite strand | 574/702 (81 %) | 0 diff (100 %id) | ||
AW994406 | breast_normal | .h-u | 1251 to 1647 | 15 to 413 | 399/424 (94 %) | 5 diff (98.9 %id) | |||
T20004 | .k-u | 240 to 496 | 258 to 1 | 258/258 (100 %) | 3 diff (98.9 %id) | ||||
BC009477 | Lung, small cell carcinoma | .a | 618 to 1452 | 1 to 835 | exact | available from MGC, AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 835/835 (100 %) | 0 diff (100 %id) |
BE065571 | breast | .h-u | 1127 to 1277 | 160 to 11 | Submitted on the opposite strand | 150/168 (89 %) | 0 diff (100 %id) | ||
BE144633 | head_neck | .j-u | 349 to 452 | 104 to 1 | Submitted on the opposite strand | 104/126 (82 %) | 3 diff (97.7 %id) | ||
BE174594 | head_neck | .h-u | 1365 to 1625 | 308 to 48 | Submitted on the opposite strand | 261/317 (82 %) | 0 diff (100 %id) | ||
BE174632 | head_neck | .h-u | 1389 to 1626 | 32 to 270 | 239/274 (87 %) | 5 diff (98.2 %id) | |||
BE185146 | head_neck | .h-u | 1302 to 1689 | 393 to 6 | Submitted on the opposite strand | 388/393 (98 %) | 0 diff (100 %id) | ||
BE708959 | head_neck | .h-u | 1365 to 1621 | 29 to 287 | 259/289 (89 %) | 9 diff (96.9 %id) | |||
BE709035 | head_neck | .h-u | 1357 to 1626 | 1 to 270 | 270/274 (98 %) | 7 diff (97.5 %id) | |||
BE709052 | head_neck | .h-u | 1365 to 1621 | 286 to 30 | 257/295 (87 %) | 0 diff (100 %id) | |||
BE719446 | head_neck | .h-u | 1140 to 1652 | 23 to 536 | 514/539 (95 %) | 6 diff (98.9 %id) | |||
BE768518 | prostate_tumor | .h-u | 1020 to 1386 | 363 to 1 | 363/363 (100 %) | 3 diff (99.2 %id) | |||
BE768551 | prostate_tumor | .h-u | 1005 to 1395 | 399 to 9 | 391/399 (97 %) | 0 diff (100 %id) | |||
BE768564 | prostate_tumor | .h-u | 989 to 1395 | 414 to 10 | 405/414 (97 %) | 0 diff (100 %id) | |||
BE768690 | prostate_tumor | .h-u | 1003 to 1391 | 389 to 1 | 389/389 (100 %) | 2 diff (99.5 %id) | |||
BE768752 | prostate_tumor | .h-u | 913 to 1261 | 348 to 1 | 348/353 (98 %) | 2 diff (99.5 %id) | |||
BE769285 | prostate_tumor | .h-u | 1560 to 1722 | 167 to 6 | 162/174 (93 %) | 0 diff (100 %id) | |||
BE772230 | prostate_tumor | .h-u | 1379 to 1616 | 238 to 3 | 236/241 (97 %) | 0 diff (100 %id) | |||
BE772232 | prostate_tumor | .h-u | 1379 to 1616 | 241 to 3 | 239/244 (97 %) | 0 diff (100 %id) | |||
BE772299 | prostate_tumor | .h-u | 1379 to 1604 | 226 to 2 | 225/229 (98 %) | 0 diff (100 %id) | |||
BE813403 | breast_normal | .h-u | 1245 to 1437 | 197 to 7 | 191/197 (96 %) | 0 diff (100 %id) | |||
BE815006 | breast_normal | .h-u | 1515 to 1679 | 164 to 1 | 164/164 (100 %) | 1 diff (99.4 %id) | |||
BE833465 | ovary | .h-u | 1405 to 1550 | 148 to 3 | 146/163 (89 %) | 0 diff (100 %id) | |||
BE840489 | prostate_normal | .h-u | 1228 to 1513 | 303 to 18 | 286/314 (91 %) | 0 diff (100 %id) | |||
BE840566 | prostate_normal | .h-u | 1228 to 1513 | 303 to 18 | 286/314 (91 %) | 0 diff (100 %id) | |||
BE840584 | prostate_normal | .h-u | 1282 to 1513 | 252 to 17 | 236/273 (86 %) | 0 diff (100 %id) | |||
BE940494 | uterus_tumor | .a | 2117 to 2306 | 204 to 14 | 191/206 (92 %) | 0 diff (100 %id) | |||
BE940501 | uterus_tumor | .a | 2117 to 2296 | 184 to 6 | 179/186 (96 %) | 0 diff (100 %id) | |||
BE940738 | uterus_tumor | .h-u | 1413 to 1605 | 12 to 204 | 193/204 (94 %) | 6 diff (97.1 %id) | |||
BF089455 | head_neck | .a | 1959 to 2305 | 363 to 19 | 345/363 (95 %) | 0 diff (100 %id) | |||
BF090404 | nervous_tumor | .h-u | 804 to 921 | 117 to 1 | 117/117 (100 %) | 4 diff (96.6 %id) | |||
BF372066 | prostate_tumor | .h-u | 1042 to 1394 | 359 to 7 | 353/359 (98 %) | 0 diff (100 %id) | |||
BF372133 | prostate_tumor | .h-u | 1106 to 1290 | 205 to 22 | 184/205 (89 %) | 11 diff (94.7 %id) | |||
BF733684 | amnion_normal | .i | 664 to 891 | 1 to 227 | tiling clone, | 227/227 (100 %) | 7 diff (97.0 %id) | ||
BF743942 | breast | .h-u | 728 to 895 | 194 to 28 | Submitted on the opposite strand | 167/194 (86 %) | 0 diff (100 %id) | ||
BF744245 | breast | .h-u | 728 to 890 | 177 to 16 | Submitted on the opposite strand | 162/177 (91 %) | 0 diff (100 %id) | ||
BF760388 | colon | .a | 943 to 1321 | 394 to 16 | Submitted on the opposite strand | 379/431 (87 %) | 1 diff (99.8 %id) | ||
BF816148 | colon_ins | .h-u | 1024 to 1603 | 18 to 594 | 577/594 (97 %) | 6 diff (99.0 %id) | |||
BF907188 | uterus_tumor | .a | 2130 to 2343 | 214 to 1 | Submitted on the opposite strand | 214/214 (100 %) | 0 diff (100 %id) | ||
BF907196 | uterus_tumor | .a | 2130 to 2343 | 214 to 1 | Submitted on the opposite strand | 214/214 (100 %) | 0 diff (100 %id) | ||
BF909128 | uterus_tumor | .h-u | 1441 to 1618 | 10 to 187 | 178/187 (95 %) | 6 diff (96.8 %id) | |||
BF911046 | uterus_tumor | .h-u | 744 to 1034 | 306 to 14 | Submitted on the opposite strand | 293/306 (95 %) | 0 diff (100 %id) | ||
BF911878 | uterus_tumor | .a | 1959 to 2306 | 357 to 14 | Submitted on the opposite strand | 344/357 (96 %) | 0 diff (100 %id) | ||
BF932637 | nervous_tumor | .a | 1085 to 1269 | 184 to 1 | Submitted on the opposite strand | 184/189 (97 %) | 5 diff (97.4 %id) | ||
BF934590 | nervous_tumor | .a | 794 to 1325 | 551 to 20 | Submitted on the opposite strand | 532/551 (96 %) | 0 diff (100 %id) | ||
BG203061 | .h-u | 945 to 1601 | 700 to 50 | Submitted on the opposite strand | 651/905 (71 %) | 0 diff (100 %id) | |||
BG673743 | Nasal biopsy | .a | 941 to 1046 | 121 to 16 | Submitted on the opposite strand | 106/125 (84 %) | 0 diff (100 %id) | ||
BG994782 | head_neck | .h-u | 1181 to 1586 | 24 to 430 | 407/430 (94 %) | 6 diff (98.7 %id) | |||
BI032912 | nervous_normal | .h-u | 1257 to 1679 | 31 to 452 | 422/452 (93 %) | 6 diff (98.7 %id) | |||
BI045110 | prostate_normal | .h-u | 1371 to 1713 | 363 to 20 | tiling clone, | 344/363 (94 %) | 0 diff (100 %id) | ||
BI049244 | placenta_normal | .h-u | 1338 to 1626 | 309 to 21 | 289/309 (93 %) | 0 diff (100 %id) | |||
BI324876 | Pancreas, Purified pancreatic islet | .h-u | 1144 to 1611 | 470 to 3 | 468/470 (99 %) | 0 diff (100 %id) | |||
BI439832 | Pancreas, Purified pancreatic islet | .h-u | 1044 to 1611 | 570 to 3 | 568/570 (99 %) | 0 diff (100 %id) | |||
BM310635 | Pancreas, Purified pancreatic islet | .a | 775 to 1361 | 587 to 1 | exact | 587/587 (100 %) | 0 diff (100 %id) | ||
BQ301422 | bocio_tumor | .c | 281 to 874 | 26 to 618 | 593/618 (95 %) | 8 diff (98.8 %id) | |||
BQ304981 | breast | .a | 777 to 1125 | 368 to 21 | 348/390 (89 %) | 6 diff (98.5 %id) | |||
BQ328996 | lung_normal | .h-u | 722 to 1069 | 350 to 1 | 350/350 (100 %) | 19 diff (94.6 %id) | |||
BQ345333 | nervous_tumor | .a | 898 to 1260 | 363 to 3 | 304/363 (83 %) | 9 diff (97.6 %id) | |||
DA055220 | cerebellum | .a | 679 to 1230 | 2 to 553 | capped | 552/552 (100 %) | 0 diff (100 %id) | ||
DA055387 | cerebellum | .a | 686 to 1249 | 2 to 565 | capped | 564/564 (100 %) | 0 diff (100 %id) | ||
DA056642 | cerebellum | .a | 685 to 1293 | 2 to 610 | exact | capped | 609/609 (100 %) | 0 diff (100 %id) | |
DA057740 | cerebellum | .a | 684 to 1257 | 2 to 575 | capped | 574/574 (100 %) | 0 diff (100 %id) | ||
DA060110 | cerebellum | .a | 650 to 1223 | 2 to 575 | capped | 574/574 (100 %) | 0 diff (100 %id) | ||
DA063261 | cerebellum | .a | 671 to 1235 | 2 to 566 | capped | 565/565 (100 %) | 0 diff (100 %id) | ||
DC304400 | cerebellum | .b | 615 to 1191 | 1 to 578 | 578/578 (100 %) | 2 diff (99.7 %id) | |||
DA075051 | cerebellum | .a | 621 to 1200 | 2 to 581 | capped | 580/580 (100 %) | 0 diff (100 %id) | ||
DA075137 | cerebellum | .a | 652 to 1230 | 2 to 580 | capped | 579/579 (100 %) | 0 diff (100 %id) | ||
DA076240 | cerebellum | .a | 671 to 1249 | 2 to 580 | capped | 579/579 (100 %) | 0 diff (100 %id) | ||
DA076589 | cerebellum | .a | 679 to 1244 | 2 to 567 | capped | 566/566 (100 %) | 0 diff (100 %id) | ||
DA130601 | alzheimer cortex | .a | 694 to 1263 | 2 to 571 | capped | 570/570 (100 %) | 0 diff (100 %id) | ||
DA134880 | alzheimer cortex | .a | 686 to 1244 | 2 to 560 | capped | 559/559 (100 %) | 0 diff (100 %id) | ||
DA140956 | alzheimer cortex | .a | 679 to 1307 | 2 to 630 | exact | capped | 629/629 (100 %) | 0 diff (100 %id) | |
DA142625 | alzheimer cortex | .a | 652 to 1217 | 2 to 567 | capped | 566/566 (100 %) | 0 diff (100 %id) | ||
DC319617 | brain | .c | 95 to 589 | 1 to 495 | 495/495 (100 %) | 2 diff (99.6 %id) | |||
DA219683 | brain | .f | 387 to 957 | 2 to 572 | exact | tiling clone, capped | 571/571 (100 %) | 0 diff (100 %id) | |
DA235059 | brain | .a | 650 to 1248 | 2 to 600 | capped | 599/599 (100 %) | 0 diff (100 %id) | ||
DA258512 | caudate nucleus | .a | 679 to 1245 | 2 to 568 | capped | 567/567 (100 %) | 0 diff (100 %id) | ||
DC327666 | caudate nucleus | .f | 1 to 563 | 2 to 565 | 565/565 (100 %) | 1 diff (99.9 %id) | |||
DA347351 | substantia nigra | .i | 1 to 566 | 2 to 567 | exact | tiling clone, capped | 566/566 (100 %) | 0 diff (100 %id) | |
DC425930. matches multiple genes | substantia nigra | .h-u | 1372 to 1689 | 319 to 1 | also hits gene SLC4A10 | 319/319 (100 %) | 3 diff (99.1 %id) | ||
DA357698 | subthalamic nucleus | .c | 180 to 740 | 2 to 564 | capped | 563/563 (100 %) | 2 diff (99.7 %id) | ||
DC338376 | subthalamic nucleus | .a | 471 to 1027 | 1 to 557 | 557/557 (100 %) | 0 diff (100 %id) | |||
DC338477 | subthalamic nucleus | .c | 130 to 706 | 1 to 577 | 577/577 (100 %) | 0 diff (100 %id) | |||
DC338583 | subthalamic nucleus | .a | 608 to 1171 | 1 to 564 | 564/564 (100 %) | 0 diff (100 %id) | |||
DA364904 | subthalamic nucleus | .a | 653 to 1210 | 2 to 559 | capped | 558/558 (100 %) | 0 diff (100 %id) | ||
DA367992 | subthalamic nucleus | .a | 676 to 1239 | 2 to 565 | capped | 564/564 (100 %) | 0 diff (100 %id) | ||
DA393105 | thalamus | .a | 676 to 1270 | 2 to 596 | capped | 595/595 (100 %) | 0 diff (100 %id) | ||
BU580903 | Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) | .a | 708 to 1331 | 1 to 624 | exact | 624/624 (100 %) | 0 diff (100 %id) | ||
BX103679 | placenta | .a | 1091 to 1816 | 1 to 727 | 727/727 (100 %) | 1 diff (99.9 %id) | |||
BX647319 | human cerebellum | .c | 162 to 1738 | 1 to 1578 | exact | tiling clone, available from DKFZ, AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 1578/1578 (100 %) | 2 diff (99.9 %id) |
BF727154 | eye, lens | .a | 633 to 1417 | 1 to 785 | exact | 785/785 (100 %) | 0 diff (100 %id) | ||
AU098410 | .a | 651 to 950 | 1 to 300 | 300/300 (100 %) | 0 diff (100 %id) | ||||
AU102572 | .b | 439 to 488 | 1 to 50 | 50/50 (100 %) | 0 diff (100 %id) | ||||
BP204705 | coronary artery | .a | 651 to 1232 | 1 to 582 | 582/582 (100 %) | 1 diff (99.9 %id) | |||
AU102573 | .b | 466 to 515 | 1 to 50 | 50/50 (100 %) | 0 diff (100 %id) | ||||
BP207658 | coronary artery | .a | 678 to 1262 | 1 to 585 | 585/585 (100 %) | 1 diff (99.9 %id) | |||
CB269642 | adipose | .a | 907 to 1528 | 1 to 622 | 622/622 (100 %) | 0 diff (100 %id) | |||
BP209291 | cerebellum | .a | 670 to 1252 | 1 to 583 | 583/583 (100 %) | 0 diff (100 %id) | |||
BP211419 | cerebrum | .a | 681 to 1259 | 1 to 579 | 579/579 (100 %) | 0 diff (100 %id) | |||
CD051242 | embryonic trophoblasts, made from WA01 stemcells | .h-u | 1055 to 1689 | 20 to 654 | 635/658 (96 %) | 3 diff (99.6 %id) | |||
CD623398 | .a | 695 to 1190 | 497 to 1 | 497/712 (69 %) | 1 diff (99.9 %id) | ||||
CD623400 | .a | 670 to 1306 | 658 to 23 | K126E | 636/689 (92 %) | 3 diff (99.6 %id) | |||
DA421206 | cervix | .a | 652 to 1214 | 2 to 564 | capped | 563/563 (100 %) | 0 diff (100 %id) | ||
DA421932 | cervix | .a | 649 to 1228 | 2 to 581 | capped | 580/580 (100 %) | 0 diff (100 %id) | ||
BX447116 | neuroblastoma | .c | 180 to 1074 | 10 to 907 | E10X A25X D26E I47* | 837/907 (92 %) | 29 diff (96.9 %id) | ||
CN411141 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .d | 1 to 580 | 17 to 597 | S88E F89L E90* | tiling clone, | 581/597 (97 %) | 8 diff (98.7 %id) | |
CN411143 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 1685 to 2368 | 695 to 12 | Submitted on the opposite strand | 684/695 (98 %) | 0 diff (100 %id) | ||
CN411144 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 699 to 1478 | 13 to 793 | exact | 781/793 (98 %) | 8 diff (99.0 %id) | ||
CN411145 | embryonic stem cells, DMSO-treated H9 cellline | .a | 695 to 1426 | 1 to 732 | exact | 732/732 (100 %) | 1 diff (99.9 %id) | ||
CN411146 | embryonic stem cells, DMSO-treated H9 cellline | .h-u | 1166 to 1690 | 54 to 578 | 525/581 (90 %) | 3 diff (99.5 %id) | |||
CN411148 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 687 to 1426 | 1 to 740 | exact | 740/740 (100 %) | 0 diff (100 %id) | ||
CN411149 | embryonic stem cells, DMSO-treated H9 cellline | .a | 740 to 1002 | 1 to 263 | 263/263 (100 %) | 0 diff (100 %id) | |||
CN411152 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 683 to 1409 | 1 to 728 | exact | 728/728 (100 %) | 1 diff (99.9 %id) | ||
CN411162 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 699 to 1247 | 1 to 549 | 549/549 (100 %) | 0 diff (100 %id) | |||
DA425817 | colon | .a | 679 to 1256 | 2 to 579 | capped | 578/578 (100 %) | 0 diff (100 %id) | ||
DA427416 | colon | .a | 677 to 1246 | 2 to 571 | capped | 570/570 (100 %) | 0 diff (100 %id) | ||
DA430900 | colon | .a | 629 to 1208 | 2 to 581 | capped | 580/580 (100 %) | 0 diff (100 %id) | ||
CR457042 | .a | 775 to 1271 | 1 to 497 | 497/498 (99 %) | 2 diff (99.6 %id) | ||||
CR541956 | .a | 775 to 1269 | 1 to 495 | 495/495 (100 %) | 0 diff (100 %id) | ||||
CR591834 | B cells (Ramos cell line) | .a | 429 to 2112 | 1 to 1684 | exact | tiling clone, | 1684/1684 (100 %) | 0 diff (100 %id) | |
CR596061 | fetal brain | .a | 692 to 2103 | 1 to 1412 | exact | 1412/1412 (100 %) | 0 diff (100 %id) | ||
CR598189 | Placenta Cot 25-normalized | .c | 169 to 1705 | 1 to 1537 | exact | tiling clone, | 1537/1537 (100 %) | 0 diff (100 %id) | |
CR601160 | Placenta Cot 25-normalized | .a | 686 to 2113 | 1 to 1428 | exact | 1428/1428 (100 %) | 0 diff (100 %id) | ||
CR602092 | adult brain | .a | 688 to 2091 | 1 to 1404 | exact | 1404/1404 (100 %) | 0 diff (100 %id) | ||
CR604335 | Neuroblastoma Cot 10-normalized | .a | 643 to 2095 | 1 to 1453 | exact | 1453/1453 (100 %) | 0 diff (100 %id) | ||
CR607210 | Placenta Cot 25-normalized | .a | 777 to 2101 | 1 to 1325 | 1325/1325 (100 %) | 0 diff (100 %id) | |||
CR608580 | Placenta Cot 25-normalized | .a | 686 to 2095 | 1 to 1410 | exact | 1410/1410 (100 %) | 0 diff (100 %id) | ||
CR609251 | Placenta Cot 25-normalized | .a | 686 to 2116 | 1 to 1431 | exact | 1431/1431 (100 %) | 0 diff (100 %id) | ||
CR610796 | fetal brain | .a | 777 to 2125 | 1 to 1349 | 1349/1349 (100 %) | 0 diff (100 %id) | |||
CR612561 | Placenta Cot 25-normalized | .a | 686 to 2304 | 1 to 1619 | exact | 1619/1619 (100 %) | 0 diff (100 %id) | ||
CR613178 | placenta | .a | 697 to 2103 | 1 to 1407 | exact | 1407/1407 (100 %) | 0 diff (100 %id) | ||
CR615007 | Placenta Cot 25-normalized | .a | 667 to 2094 | 1 to 1428 | exact | 1428/1428 (100 %) | 0 diff (100 %id) | ||
CR622679 | placenta | .a | 686 to 2057 | 1 to 1372 | exact | 1372/1372 (100 %) | 0 diff (100 %id) | ||
CR623027 | fetal brain | .a | 632 to 1484 | 1 to 853 | exact | 853/853 (100 %) | 0 diff (100 %id) | ||
CR623701 | Placenta Cot 25-normalized | .a | 692 to 2096 | 1 to 1405 | exact | 1405/1405 (100 %) | 0 diff (100 %id) | ||
BX331617 | Neuroblastoma Cot 10-normalized | .h-u | 828 to 1690 | 4 to 866 | tiling clone, | 863/866 (99 %) | 6 diff (99.4 %id) | ||
BX438746 | placenta | .a | 777 to 1652 | 1 to 876 | 876/876 (100 %) | 0 diff (100 %id) | |||
BX418648 | brain, fetal brain | .a | 696 to 1586 | 1 to 891 | exact | 891/891 (100 %) | 0 diff (100 %id) | ||
BX441909 | brain, fetal brain | .a | 686 to 1655 | 1 to 958 | A35X S88X A105X P106X | 958/976 (98 %) | 20 diff (98.0 %id) | ||
BX442005 | brain, fetal brain | .a | 658 to 1705 | 1 to 1042 | exact | 1042/1096 (95 %) | 9 diff (99.2 %id) | ||
BX413855 | brain, fetal brain | .a | 1423 to 2125 | 698 to 1 | fully sequenced, | 698/698 (100 %) | 5 diff (99.3 %id) | ||
BX442853 | brain, fetal brain | .a | 777 to 1453 | 1 to 670 | fully sequenced, | 670/670 (100 %) | 1 diff (99.9 %id) | ||
BX351480 | Placenta Cot 25-normalized | .h-u | 807 to 1689 | 878 to 1 | 878/886 (99 %) | 24 diff (97.3 %id) | |||
AL544549 | placenta, Placenta Cot 25-normalized | .a | 686 to 1408 | 1 to 707 | exact | fully sequenced, | 707/707 (100 %) | 0 diff (100 %id) | |
AL570636 | placenta, Placenta Cot 25-normalized | .a | 1378 to 2304 | 919 to 1 | fully sequenced, | 919/919 (100 %) | 8 diff (99.2 %id) | ||
AL551241 | placenta, Placenta Cot 25-normalized | .c | 722 to 1705 | 993 to 1 | fully sequenced, | 965/965 (100 %) | 17 diff (98.3 %id) | ||
AL551267 | placenta, Placenta Cot 25-normalized | .c | 169 to 752 | 1 to 583 | fully sequenced, | 583/583 (100 %) | 2 diff (99.7 %id) | ||
AL553445 | placenta, Placenta Cot 25-normalized | .a | 777 to 1424 | 1 to 647 | fully sequenced, | 647/647 (100 %) | 0 diff (100 %id) | ||
AL576550 | placenta, Placenta Cot 25-normalized | .a | 1394 to 2101 | 707 to 1 | fully sequenced, | 707/707 (100 %) | 1 diff (99.9 %id) | ||
BX422818 | adult brain, brain | .a | 667 to 1655 | 1 to 981 | exact | 981/985 (99 %) | 9 diff (99.1 %id) | ||
AL532747 | adult brain, brain | .a | 647 to 1682 | 1 to 1014 | exact | fully sequenced, | 1014/1014 (100 %) | 19 diff (98.2 %id) | |
AL564860 | adult brain, brain | .a | 1652 to 2309 | 689 to 29 | fully sequenced, | 661/689 (95 %) | 11 diff (98.5 %id) | ||
BX410255 | adult brain, brain | .a | 1708 to 2316 | 197 to 806 | 610/814 (74 %) | 6 diff (99.3 %id) | |||
CA391670 | eye, RPE/choroid | .a | 723 to 1349 | 1 to 627 | exact | 627/627 (100 %) | 0 diff (100 %id) | ||
CA396860 | eye, RPE/choroid | .a | 687 to 1297 | 1 to 611 | exact | 611/611 (100 %) | 0 diff (100 %id) | ||
DA459314 | tongue, tumor tissue | .g | 394 to 965 | 2 to 573 | exact | tiling clone, capped | 572/572 (100 %) | 1 diff (99.9 %id) | |
CU446075 | epidermis | .h-u | 822 to 1581 | 773 to 14 | Submitted on the opposite strand | 760/773 (98 %) | 0 diff (100 %id) | ||
CU446372 | epidermis | .a | 727 to 1073 | 1 to 348 | 348/374 (93 %) | 10 diff (97.4 %id) | |||
CU448721 | epidermis | .h-u | 798 to 1581 | 797 to 14 | Submitted on the opposite strand | 784/798 (98 %) | 0 diff (100 %id) | ||
CU450975 | epidermis | .a | 1044 to 1785 | 1 to 742 | 742/742 (100 %) | 7 diff (99.1 %id) | |||
AL134598 | brain | .h-u | 1321 to 1689 | 1 to 369 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 369/369 (100 %) | 0 diff (100 %id) | |
BX472218 | .c | 266 to 454 | 1 to 189 | 189/189 (100 %) | 9 diff (95.3 %id) | ||||
BP227310 | .a | 649 to 1230 | 1 to 582 | 582/582 (100 %) | 0 diff (100 %id) | ||||
DT216394 | brain | .a | 796 to 1478 | 1 to 683 | 683/683 (100 %) | 0 diff (100 %id) | |||
DW425454 | Liver | .a | 632 to 871 | 15 to 252 | AAA | 238/253 (94 %) | 16 diff (93.7 %id) | ||
DW447108 | Liver | .k-u | 163 to 360 | 17 to 214 | 198/214 (92 %) | 6 diff (97.2 %id) | |||
EC440690 | Prostate | .h-u | 1589 to 1688 | 104 to 3 | 102/104 (98 %) | 0 diff (100 %id) | |||
EC457542 | Prostate | .h-u | 1501 to 1587 | 21 to 105 | 85/105 (80 %) | 6 diff (94.3 %id) | |||
EC459416 | Prostate | .h-u | 1199 to 1297 | 12 to 105 | 94/105 (89 %) | 6 diff (94.3 %id) | |||
EC517775 | Prostate | .h-u | 1193 to 1297 | 1 to 102 | 102/102 (100 %) | 6 diff (94.2 %id) | |||
EC572162 | Prostate | .h-u | 1513 to 1613 | 1 to 101 | 101/101 (100 %) | 1 diff (99.1 %id) | |||
DC427914 | .c | 130 to 727 | 1 to 598 | 598/598 (100 %) | 0 diff (100 %id) | ||||
FN047318 | breast carcinoma | .h-u | 1365 to 1452 | 88 to 1 | Submitted on the opposite strand | 88/88 (100 %) | 1 diff (98.9 %id) | ||
FN052330 | breast carcinoma | .h-u | 1255 to 1358 | 103 to 1 | Submitted on the opposite strand | 103/103 (100 %) | 1 diff (99.1 %id) | ||
FN056383 | breast carcinoma | .h-u | 1081 to 1159 | 1 to 79 | 79/84 (94 %) | 5 diff (94.1 %id) | |||
FN058422 | breast carcinoma | .h-u | 1312 to 1407 | 96 to 1 | Submitted on the opposite strand | 96/96 (100 %) | 0 diff (100 %id) | ||
FN060934 | breast carcinoma | .a | 2165 to 2258 | 1 to 94 | 94/94 (100 %) | 5 diff (94.7 %id) | |||
FN063400 | breast carcinoma | .h-u | 1545 to 1633 | 1 to 86 | 86/92 (93 %) | 4 diff (95.7 %id) | |||
FN064955 | breast carcinoma | .h-u | 1494 to 1589 | 1 to 98 | 98/98 (100 %) | 2 diff (98.0 %id) | |||
FN068690 | breast carcinoma | .h-u | 1494 to 1589 | 1 to 96 | 96/96 (100 %) | 0 diff (100 %id) | |||
FN069253 | breast carcinoma | .h-u | 1440 to 1523 | 1 to 80 | 80/80 (100 %) | 4 diff (95.0 %id) | |||
FN070893 | breast carcinoma | .h-u | 1174 to 1228 | 59 to 6 | Submitted on the opposite strand | 54/63 (85 %) | 0 diff (100 %id) | ||
FN072861 | breast carcinoma | .h-u | 1639 to 1687 | 1 to 49 | 49/50 (98 %) | 1 diff (98.0 %id) | |||
FN074612 | breast carcinoma | .h-u | 1444 to 1525 | 80 to 1 | Submitted on the opposite strand | 80/81 (98 %) | 2 diff (97.6 %id) | ||
FN082917 | breast carcinoma | .h-u | 1541 to 1618 | 1 to 76 | 76/80 (95 %) | 3 diff (96.3 %id) | |||
FN084705 | breast carcinoma | .h-u | 1458 to 1549 | 1 to 92 | 92/92 (100 %) | 0 diff (100 %id) | |||
FN085813 | breast carcinoma | .h-u | 1301 to 1385 | 85 to 1 | Submitted on the opposite strand | 85/85 (100 %) | 0 diff (100 %id) | ||
FN085960 | breast carcinoma | .h-u | 1601 to 1666 | 1 to 66 | 66/67 (98 %) | 3 diff (95.6 %id) | |||
FN095277 | breast carcinoma | .h-u | 732 to 789 | 61 to 5 | Submitted on the opposite strand | 57/64 (89 %) | 0 diff (100 %id) | ||
FN096584 | breast carcinoma | .h-u | 1348 to 1430 | 1 to 83 | 83/89 (93 %) | 4 diff (95.6 %id) | |||
FN098275 | breast carcinoma | .h-u | 1361 to 1446 | 1 to 86 | 86/86 (100 %) | 4 diff (95.4 %id) | |||
FN099297 | breast carcinoma | .h-u | 1032 to 1138 | 1 to 104 | 104/107 (97 %) | 4 diff (96.3 %id) | |||
FN100771 | breast carcinoma | .h-u | 1414 to 1503 | 1 to 90 | 90/90 (100 %) | 0 diff (100 %id) | |||
FN101454 | breast carcinoma | .a | 2186 to 2267 | 1 to 81 | 81/94 (86 %) | 3 diff (96.9 %id) | |||
FN102335 | breast carcinoma | .h-u | 1466 to 1552 | 97 to 10 | Submitted on the opposite strand | 88/97 (90 %) | 0 diff (100 %id) | ||
FN105656 | breast carcinoma | .h-u | 1481 to 1548 | 1 to 68 | 68/69 (98 %) | 1 diff (98.6 %id) | |||
FN106898 | breast carcinoma | .h-u | 1475 to 1557 | 83 to 1 | Submitted on the opposite strand | 83/92 (90 %) | 0 diff (100 %id) | ||
FN109500 | breast carcinoma | .h-u | 1038 to 1146 | 1 to 112 | 112/113 (99 %) | 7 diff (93.9 %id) | |||
FN113878 | breast carcinoma | .h-u | 1050 to 1133 | 84 to 1 | Submitted on the opposite strand | 84/84 (100 %) | 0 diff (100 %id) | ||
FN114120 | breast carcinoma | .h-u | 1340 to 1432 | 93 to 1 | Submitted on the opposite strand | 93/93 (100 %) | 0 diff (100 %id) | ||
FN120157 | breast carcinoma | .h-u | 1110 to 1184 | 75 to 3 | Submitted on the opposite strand | 73/76 (96 %) | 0 diff (100 %id) | ||
FN122321 | breast carcinoma | .h-u | 1312 to 1403 | 94 to 4 | Submitted on the opposite strand | 91/94 (96 %) | 0 diff (100 %id) | ||
FN127039 | breast carcinoma | .a | 2144 to 2240 | 1 to 97 | 97/97 (100 %) | 4 diff (95.9 %id) | |||
FN130804 | breast carcinoma | .a | 1086 to 1136 | 52 to 1 | Submitted on the opposite strand | 52/52 (100 %) | 2 diff (96.2 %id) | ||
FN131992 | breast carcinoma | .a | 1120 to 1211 | 1 to 93 | 93/93 (100 %) | 6 diff (93.6 %id) | |||
FN133142 | breast carcinoma | .h-u | 1431 to 1507 | 75 to 1 | Submitted on the opposite strand | 75/84 (89 %) | 2 diff (97.7 %id) | ||
FN134919 | breast carcinoma | .a | 2098 to 2199 | 107 to 5 | Submitted on the opposite strand | 103/107 (96 %) | 0 diff (100 %id) | ||
FN135739 | breast carcinoma | .a | 2186 to 2283 | 1 to 96 | 96/96 (100 %) | 6 diff (93.8 %id) | |||
FN136255 | breast carcinoma | .a | 2216 to 2311 | 1 to 95 | 95/96 (98 %) | 2 diff (98.0 %id) | |||
FN137823 | breast carcinoma | .h-u | 997 to 1090 | 90 to 1 | Submitted on the opposite strand | 90/92 (97 %) | 4 diff (95.7 %id) | ||
FN138222 | breast carcinoma | .h-u | 1613 to 1687 | 78 to 3 | Submitted on the opposite strand | 76/78 (97 %) | 0 diff (100 %id) | ||
FN140658 | breast carcinoma | .a | 2295 to 2369 | 76 to 1 | Submitted on the opposite strand | 76/76 (100 %) | 2 diff (97.4 %id) | ||
FN141003 | breast carcinoma | .h-u | 1517 to 1617 | 1 to 101 | 101/101 (100 %) | 0 diff (100 %id) | |||
FN143655 | breast carcinoma | .a | 2168 to 2259 | 1 to 88 | 88/88 (100 %) | 4 diff (95.5 %id) | |||
FN151253 | breast carcinoma | .h-u | 1334 to 1415 | 80 to 1 | Submitted on the opposite strand | 80/86 (93 %) | 2 diff (97.7 %id) | ||
FN152040 | breast carcinoma | .a | 2118 to 2220 | 101 to 1 | Submitted on the opposite strand | 101/101 (100 %) | 3 diff (97.1 %id) | ||
FN152997 | breast carcinoma | .a | 2208 to 2300 | 1 to 89 | 89/89 (100 %) | 5 diff (94.4 %id) | |||
FN155014 | breast carcinoma | .h-u | 1512 to 1613 | 1 to 101 | 101/101 (100 %) | 1 diff (99.1 %id) | |||
FN157094 | breast carcinoma | .h-u | 1383 to 1474 | 1 to 94 | 94/94 (100 %) | 8 diff (91.5 %id) | |||
FN157701 | breast carcinoma | .h-u | 1512 to 1608 | 96 to 1 | Submitted on the opposite strand | 96/96 (100 %) | 1 diff (99.0 %id) | ||
FN164411 | breast carcinoma | .a | 2171 to 2262 | 90 to 1 | Submitted on the opposite strand | 90/90 (100 %) | 2 diff (97.8 %id) | ||
FN166889 | breast carcinoma | .h-u | 1342 to 1436 | 1 to 94 | 94/94 (100 %) | 1 diff (99.0 %id) | |||
FN171111 | breast carcinoma | .a | 2050 to 2159 | 1 to 111 | 111/111 (100 %) | 3 diff (97.3 %id) | |||
FN172306 | breast carcinoma | .h-u | 1463 to 1555 | 1 to 93 | 93/96 (96 %) | 1 diff (99.0 %id) | |||
FN174892 | breast carcinoma | .h-u | 994 to 1081 | 1 to 85 | 85/89 (95 %) | 5 diff (94.4 %id) | |||
FN175253 | breast carcinoma | .h-u | 1456 to 1547 | 1 to 90 | 90/91 (98 %) | 3 diff (96.8 %id) | |||
AV654351 | corresponding non cancerous liver tissue | .a | 623 to 1287 | 1 to 666 | K125X L152V I157X V158C A159S ... | Submitted on the opposite strand | 666/666 (100 %) | 6 diff (99.1 %id) | |
DB526824 | testis | .k-u | 1 to 448 | 1 to 448 | tiling clone, | Submitted on the opposite strand | 448/448 (100 %) | 0 diff (100 %id) | |
DB554757 | hypothalamus | .h-u | 1168 to 1609 | 1 to 443 | Submitted on the opposite strand | 443/443 (100 %) | 3 diff (99.4 %id) | ||
DB501005 | hypothalamus | .a | 657 to 1149 | 1 to 493 | 493/493 (100 %) | 1 diff (99.8 %id) | |||
DB572184 | hypothalamus | .a | 998 to 1452 | 1 to 455 | AAA | Submitted on the opposite strand | 455/455 (100 %) | 0 diff (100 %id) | |
AI753389 | bone marrow stroma | .h-u | 1215 to 1617 | 425 to 23 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 403/403 (100 %) | 0 diff (100 %id) | |
BY795427 | eye | .a | 695 to 1330 | 1 to 636 | exact | 636/636 (100 %) | 0 diff (100 %id) | ||
DC356398 | heart | .a | 678 to 1479 | 1 to 800 | exact | 800/800 (100 %) | 9 diff (98.9 %id) | ||
DC426096 | heart | .a | 1868 to 2367 | 497 to 1 | 497/497 (100 %) | 13 diff (97.4 %id) | |||
BJ991204 | hepatoblastoma | .a | 652 to 1232 | 1 to 582 | 582/582 (100 %) | 5 diff (99.2 %id) | |||
BJ991205 | hepatoblastoma | .a | 1808 to 2347 | 540 to 1 | 540/540 (100 %) | 0 diff (100 %id) | |||
BP248033 | Kidney | .f | 382 to 963 | 1 to 582 | C46R V57D L84V K92Q E97D ... | 582/583 (99 %) | 15 diff (97.5 %id) | ||
DC358229 | lung | .g | 17 to 575 | 1 to 559 | tiling clone, | 559/559 (100 %) | 1 diff (99.9 %id) | ||
DA586976 | lung | .a | 679 to 1269 | 2 to 592 | capped | 591/591 (100 %) | 0 diff (100 %id) | ||
DA590859 | lung | .a | 714 to 1270 | 2 to 558 | capped | 557/557 (100 %) | 0 diff (100 %id) | ||
DA591582 | lung | .a | 652 to 1238 | 2 to 588 | capped | 587/587 (100 %) | 0 diff (100 %id) | ||
DA593410 | lung | .a | 652 to 1216 | 2 to 566 | capped | 565/565 (100 %) | 0 diff (100 %id) | ||
DA594626 | lung | .a | 671 to 1236 | 2 to 567 | capped | 566/566 (100 %) | 0 diff (100 %id) | ||
CD677512 | eye, Trabecular meshwork | .a | 809 to 1365 | 1 to 557 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 557/557 (100 %) | 0 diff (100 %id) | |
CD679120 | eye, Trabecular meshwork | .h-u | 1424 to 1689 | 1 to 266 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 266/266 (100 %) | 0 diff (100 %id) | |
CD679229 | eye, Trabecular meshwork | .h-u | 1375 to 1689 | 1 to 315 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 315/316 (99 %) | 1 diff (99.7 %id) | |
BP255234 | Kidney | .h-u | 1149 to 1689 | 1 to 541 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 541/541 (100 %) | 0 diff (100 %id) | |
AU102574 | .b | 458 to 507 | 1 to 50 | 50/50 (100 %) | 0 diff (100 %id) | ||||
BP255917 | Kidney | .a | 670 to 1250 | 1 to 582 | 582/582 (100 %) | 3 diff (99.5 %id) | |||
CN481337 | eye | .a | 674 to 1282 | 1 to 609 | exact | 609/609 (100 %) | 0 diff (100 %id) | ||
CN481683 | eye | .a | 719 to 1328 | 1 to 610 | exact | 610/610 (100 %) | 0 diff (100 %id) | ||
CN482756 | eye | .a | 520 to 1135 | 1 to 616 | 616/616 (100 %) | 0 diff (100 %id) | |||
CN482792 | eye | .a | 687 to 1299 | 1 to 613 | exact | 613/613 (100 %) | 0 diff (100 %id) | ||
N32902 | placenta | .h-u | 1227 to 1689 | 466 to 1 | 466/466 (100 %) | 8 diff (98.3 %id) | |||
N92323 | lung | .h-u | 1286 to 1683 | 400 to 1 | 400/461 (86 %) | 6 diff (98.7 %id) | |||
W24484 | lung | .h-u | 972 to 1262 | 1 to 292 | 292/306 (95 %) | 3 diff (99.1 %id) | |||
W44953 | senescent fibroblast | .h-u | 1294 to 1698 | 409 to 1 | 409/409 (100 %) | 4 diff (99.1 %id) | |||
AA036892 | uterus | .h-u | 1208 to 1686 | 488 to 3 | 486/488 (99 %) | 0 diff (100 %id) | |||
AA286676 | germinal center B cell | .a | 1035 to 1483 | 443 to 1 | fully sequenced, | 443/443 (100 %) | 0 diff (100 %id) | ||
AA287439 | germinal center B cell | .a | 699 to 1065 | 10 to 376 | fully sequenced, | 367/376 (97 %) | 0 diff (100 %id) | ||
AA478753 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .h-u | 1189 to 1635 | 1 to 448 | 448/469 (95 %) | 15 diff (96.9 %id) | |||
AA424824. matches multiple genes | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .h-u | 1195 to 1613 | 426 to 7 | also hits gene C9orf3 | 420/426 (98 %) | 0 diff (100 %id) | ||
AA534639 | colon | .h-u | 1120 to 1689 | 567 to 1 | 567/568 (99 %) | 16 diff (97.2 %id) | |||
AA502969 | Prostate | .h-u | 1323 to 1690 | 9 to 376 | 368/376 (97 %) | 6 diff (98.5 %id) | |||
AA507525 | Prostate | .h-u | 1334 to 1689 | 1 to 356 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 356/356 (100 %) | 3 diff (99.2 %id) | |
AA643604 | colon, colon tumor RER+ | .h-u | 1351 to 1615 | 266 to 2 | 265/266 (99 %) | 0 diff (100 %id) | |||
AA631345 | colon, colon tumor RER+ | .h-u | 1441 to 1689 | 260 to 12 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 249/249 (100 %) | 12 diff (95.2 %id) | |
AA744995 | Ewing's sarcoma | .a | 861 to 1151 | 316 to 22 | 295/330 (89 %) | 0 diff (100 %id) | |||
AA809254 | Ewing's sarcoma | .a | 1877 to 2368 | 494 to 2 | 493/494 (99 %) | 0 diff (100 %id) | |||
AA747359 | Ewing's sarcoma | .h-u | 725 to 1048 | 381 to 58 | 324/381 (85 %) | 0 diff (100 %id) | |||
AA858282 | Kidney | .h-u | 1225 to 1609 | 385 to 1 | 385/385 (100 %) | 0 diff (100 %id) | |||
AA860519 | parathyroid gland, parathyroid tumor | .h-u | 1086 to 1689 | 607 to 12 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 596/596 (100 %) | 14 diff (97.7 %id) | |
AA860607 | parathyroid gland, parathyroid tumor | .h-u | 1188 to 1689 | 513 to 12 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 502/502 (100 %) | 3 diff (99.5 %id) | |
AA838244 | epithelium (cell line), Prostate | .a | 939 to 1451 | 514 to 1 | 514/514 (100 %) | 12 diff (97.7 %id) | |||
AA916369 | breast | .h-u | 1243 to 1687 | 445 to 1 | 445/445 (100 %) | 19 diff (95.8 %id) | |||
AA883673 | pooled | .h-u | 1197 to 1690 | 492 to 1 | 492/513 (95 %) | 8 diff (98.5 %id) | |||
AI793166 | carcinoid, lung | .h-u | 864 to 1615 | 750 to 1 | Submitted on the opposite strand | 750/750 (100 %) | 14 diff (98.2 %id) | ||
AI037975 | senescent fibroblast | .h-u | 1135 to 1690 | 557 to 4 | 554/557 (99 %) | 0 diff (100 %id) | |||
AI147657 | uterus | .a | 735 to 888 | 177 to 18 | 160/177 (90 %) | 0 diff (100 %id) | |||
AI150734 | heart | .h-u | 1143 to 1609 | 467 to 1 | 467/467 (100 %) | 1 diff (99.8 %id) | |||
AI150367 | .h-u | 1261 to 1618 | 360 to 3 | 358/360 (99 %) | 0 diff (100 %id) | ||||
AI242669 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .h-u | 1214 to 1617 | 404 to 1 | 404/404 (100 %) | 0 diff (100 %id) | |||
AI261910 | Kidney | .h-u | 1014 to 1689 | 681 to 12 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 670/679 (98 %) | 20 diff (97.1 %id) | |
AI288923 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .h-u | 1207 to 1681 | 475 to 1 | 475/475 (100 %) | 4 diff (99.2 %id) | |||
AI333855 | lung | .h-u | 1088 to 1615 | 528 to 1 | 528/528 (100 %) | 4 diff (99.3 %id) | |||
AI281854 | colon, moderately-differentiated adenocarcinoma | .h-u | 514 to 921 | 418 to 11 | exact | tiling clone, AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 408/408 (100 %) | 0 diff (100 %id) |
AI270617 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .h-u | 1253 to 1689 | 432 to 1 | 432/432 (100 %) | 5 diff (98.9 %id) | |||
AI273118 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .h-u | 1285 to 1690 | 403 to 1 | 403/403 (100 %) | 7 diff (98.3 %id) | |||
AI367556 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .h-u | 1236 to 1689 | 454 to 1 | 454/454 (100 %) | 7 diff (98.5 %id) | |||
AI358859 | brain, glioblastoma (pooled) | .h-u | 1364 to 1690 | 333 to 6 | 328/334 (98 %) | 0 diff (100 %id) | |||
AI379320 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .h-u | 1014 to 1618 | 602 to 6 | 597/602 (99 %) | 0 diff (100 %id) | |||
AI422016 | brain, glioblastoma (pooled) | .h-u | 1130 to 1686 | 555 to 1 | 555/559 (99 %) | 4 diff (99.3 %id) | |||
AI492241 | B-cell, chronic lymphotic leukemia | .h-u | 1074 to 1696 | 634 to 21 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 614/616 (99 %) | 12 diff (98.1 %id) | |
AI419813 | pooled | .h-u | 967 to 1690 | 717 to 2 | 716/717 (99 %) | 0 diff (100 %id) | |||
AI470462 | pooled | .h-u | 1304 to 1689 | 398 to 13 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 386/395 (97 %) | 11 diff (97.3 %id) | |
AI458316 | carcinoid, lung | .h-u | 973 to 1613 | 635 to 1 | 635/638 (99 %) | 10 diff (98.5 %id) | |||
AI570380 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .k-u | 430 to 836 | 439 to 33 | N4T | tiling clone, AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 407/410 (99 %) | 0 diff (100 %id) |
AI801312 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .h-u | 1313 to 1689 | 407 to 31 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 377/377 (100 %) | 0 diff (100 %id) | |
AI554262 | poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus | .h-u | 1056 to 1689 | 629 to 1 | 629/638 (98 %) | 22 diff (96.6 %id) | |||
AI564997 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .h-u | 1080 to 1689 | 610 to 1 | 610/614 (99 %) | 5 diff (99.2 %id) | |||
AI659490 | Prostate | .h-u | 1108 to 1690 | 587 to 7 | 581/587 (98 %) | 0 diff (100 %id) | |||
AI597800 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .h-u | 1010 to 1681 | 670 to 1 | 670/670 (100 %) | 28 diff (95.9 %id) | |||
AI597935 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .h-u | 991 to 1697 | 706 to 1 | 706/706 (100 %) | 13 diff (98.2 %id) | |||
AI810386 | Prostate | .h-u | 1294 to 1689 | 424 to 29 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 396/396 (100 %) | 17 diff (95.8 %id) | |
AI701327 | Prostate | .h-u | 1252 to 1604 | 418 to 64 | 355/418 (84 %) | 0 diff (100 %id) | |||
AI682526 | Prostate | .h-u | 1376 to 1689 | 324 to 11 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 314/314 (100 %) | 4 diff (98.8 %id) | |
AI797083 | carcinoid, lung | .h-u | 883 to 1690 | 814 to 5 | 810/826 (98 %) | 0 diff (100 %id) | |||
AI765333 | 2 pooled tumors (clear cell type), Kidney | .h-u | 1061 to 1691 | 644 to 14 | 631/644 (97 %) | 0 diff (100 %id) | |||
AI819804 | lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) | .h-u | 936 to 1690 | 756 to 2 | 755/756 (99 %) | 0 diff (100 %id) | |||
AI818050 | normal prostate, Prostate | .h-u | 1229 to 1690 | 466 to 5 | 462/466 (99 %) | 0 diff (100 %id) | |||
AI873593 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .h-u | 1394 to 1689 | 293 to 1 | 293/294 (99 %) | 7 diff (97.7 %id) | |||
AI933575 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .h-u | 1403 to 1689 | 284 to 1 | 284/288 (98 %) | 5 diff (98.3 %id) | |||
AI924272 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .h-u | 1272 to 1690 | 419 to 1 | 419/419 (100 %) | 6 diff (98.6 %id) | |||
AI978858 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .h-u | 968 to 1689 | 721 to 1 | 721/721 (100 %) | 11 diff (98.5 %id) | |||
AI986264 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .h-u | 983 to 1690 | 709 to 4 | 706/709 (99 %) | 0 diff (100 %id) | |||
AI815703 | brain, frontal lobe | .a | 670 to 1139 | 1 to 470 | fully sequenced, | 470/470 (100 %) | 0 diff (100 %id) | ||
AI880003 | brain, frontal lobe | .a | 1109 to 1427 | 320 to 1 | fully sequenced, | 320/320 (100 %) | 1 diff (99.7 %id) | ||
AW008230 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .h-u | 1009 to 1690 | 684 to 1 | 684/684 (100 %) | 4 diff (99.5 %id) | |||
AW008236 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .h-u | 1080 to 1688 | 611 to 4 | 608/615 (98 %) | 0 diff (100 %id) | |||
AW008431 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .h-u | 1160 to 1686 | 525 to 1 | 525/525 (100 %) | 2 diff (99.7 %id) | |||
AI955220 | brain, four pooled pituitary adenomas | .h-u | 974 to 1689 | 714 to 1 | 714/714 (100 %) | 15 diff (97.9 %id) | |||
AI950499 | lung, two pooled squamous cell carcinomas | .h-u | 1300 to 1699 | 401 to 1 | 401/405 (99 %) | 12 diff (97.1 %id) | |||
AW103880 | ovary, tumor, 5 pooled (see description) | .h-u | 1205 to 1683 | 477 to 1 | 477/477 (100 %) | 3 diff (99.4 %id) | |||
AW130563 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .i | 544 to 997 | 455 to 1 | tiling clone, | 455/455 (100 %) | 7 diff (98.5 %id) | ||
AW173478 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .h-u | 1063 to 1686 | 624 to 1 | 624/624 (100 %) | 3 diff (99.6 %id) | |||
AW189315 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .h-u | 1050 to 1689 | 654 to 14 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 641/641 (100 %) | 21 diff (96.8 %id) | |
AW270870 | Kidney | .h-u | 1119 to 1689 | 570 to 1 | 570/570 (100 %) | 5 diff (99.2 %id) | |||
AW156919 | brain, frontal lobe | .h-u | 1015 to 1696 | 691 to 11 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 681/681 (100 %) | 11 diff (98.4 %id) | |
AW514806 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .h-u | 1097 to 1690 | 596 to 1 | 596/596 (100 %) | 4 diff (99.4 %id) | |||
AW269495 | lung, two pooled squamous cell carcinomas | .h-u | 1089 to 1690 | 602 to 1 | 602/602 (100 %) | 0 diff (100 %id) | |||
AW338084 | adenocarcinoma, Pancreas | .h-u | 1063 to 1693 | 629 to 1 | 629/629 (100 %) | 14 diff (97.8 %id) | |||
AW440602 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .h-u | 1070 to 1693 | 637 to 15 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 623/626 (99 %) | 11 diff (98.3 %id) | |
AW439557 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .h-u | 1075 to 1690 | 618 to 2 | 617/621 (99 %) | 0 diff (100 %id) | |||
AW661885 | colon, moderately-differentiated adenocarcinoma | .h-u | 1120 to 1689 | 572 to 1 | 572/572 (100 %) | 10 diff (98.3 %id) | |||
BE044802 | follicular adenoma (benign lesion), thyroid | .h-u | 1231 to 1607 | 40 to 419 | Submitted on the opposite strand | 380/419 (90 %) | 6 diff (98.6 %id) | ||
AW772403 | Kidney | .h-u | 1063 to 1690 | 630 to 4 | 627/630 (99 %) | 0 diff (100 %id) | |||
BM988393 | lung, Metastatic Chondrosarcoma | .h-u | 1379 to 1683 | 330 to 26 | AAA | 305/312 (97 %) | 0 diff (100 %id) | ||
BE502759 | carcinoid, lung | .h-u | 1088 to 1644 | 1 to 557 | Submitted on the opposite strand | 557/557 (100 %) | 3 diff (99.5 %id) | ||
BF590698 | colon, colon tumor, RER+ | .h-u | 1193 to 1690 | 501 to 4 | 498/501 (99 %) | 0 diff (100 %id) | |||
BE542192 | cervix | .h-u | 959 to 1676 | 1 to 717 | 717/719 (99 %) | 16 diff (97.8 %id) | |||
BE394028 | endometrium, adenocarcinoma cell line, uterus | .a | 734 to 1427 | 1 to 693 | I148X | AAA | 693/713 (97 %) | 10 diff (98.6 %id) | |
BF030019 | hypernephroma, Kidney | .c | 259 to 944 | 1 to 667 | C22V L23S S24V A25Q D26T ... | 670/726 (92 %) | 34 diff (95.4 %id) | ||
BF669872 | brain, primitive neuroectoderm | .c | 161 to 696 | 1 to 547 | 547/867 (63 %) | 37 diff (95.8 %id) | |||
BG109717 | Bone, osteosarcoma, cell line | .h-u | 1128 to 1705 | 1 to 580 | 580/748 (77 %) | 8 diff (99.0 %id) | |||
BG028814 | Bone, osteosarcoma, cell line | .h-u | 921 to 1688 | 1 to 758 | 758/787 (96 %) | 40 diff (95.0 %id) | |||
BG163682 | hypernephroma, cell line, Kidney | .c | 136 to 902 | 1 to 763 | T8N P9Q E10K E11K I12S ... | 696/793 (87 %) | 36 diff (95.5 %id) | ||
BG168215 | hypernephroma, cell line, Kidney | .c | 129 to 714 | 1 to 585 | 585/585 (100 %) | 3 diff (99.5 %id) | |||
BG291065 | bladder, transitional cell papilloma, cell line | .h-u | 1277 to 1699 | 1 to 423 | AAA | 423/428 (98 %) | 1 diff (99.8 %id) | ||
BG623262 | placenta | .a | 759 to 1065 | 1 to 307 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 307/333 (92 %) | 3 diff (99.1 %id) | |
BG719256 | testis | .g | 414 to 1006 | 1 to 606 | K22R E27D E28R I29N K30H ... | tiling clone, | 606/606 (100 %) | 22 diff (96.4 %id) | |
BI094139 | cervix | .a | 1794 to 2367 | 1 to 574 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 574/574 (100 %) | 0 diff (100 %id) | |
BI258577 | cervical carcinoma cell line, cervix | .a | 696 to 1444 | 1 to 752 | exact | 752/906 (83 %) | 6 diff (99.4 %id) | ||
BI857318 | breast, mammary adenocarcinoma, cell line | .a | 685 to 1457 | 1 to 774 | exact | 774/774 (100 %) | 7 diff (99.1 %id) | ||
BM474495 | leiomyosarcoma, uterus | .a | 692 to 1635 | 1 to 952 | exact | 952/997 (95 %) | 17 diff (98.3 %id) | ||
BM470363 | melanotic melanoma, skin | .a | 656 to 1371 | 1 to 717 | exact | 717/1075 (66 %) | 5 diff (99.6 %id) | ||
BM542202 | melanotic melanoma, skin | .a | 687 to 1494 | 1 to 815 | exact | 815/902 (90 %) | 11 diff (98.8 %id) | ||
BM459098 | melanotic melanoma, skin | .a | 1144 to 2127 | 1 to 996 | 996/1019 (97 %) | 24 diff (97.7 %id) | |||
BM801724 | duodenal adenocarcinoma, cell line, small intestine | .a | 655 to 1547 | 1 to 904 | exact | 904/916 (98 %) | 14 diff (98.5 %id) | ||
BM923390 | pooled colon, kidney, stomach | .h-u | 1045 to 1611 | 12 to 578 | 567/578 (98 %) | 0 diff (100 %id) | |||
BQ269599 | Pancreas, Purified pancreatic islet | .a | 1132 to 1484 | 355 to 3 | fully sequenced, | 353/355 (99 %) | 0 diff (100 %id) | ||
BQ286237 | Pancreas, Purified pancreatic islet | .a | 708 to 1193 | 1 to 486 | fully sequenced, | 486/486 (100 %) | 0 diff (100 %id) | ||
BQ001050 | lung, Metastatic Chondrosarcoma | .h-u | 1309 to 1689 | 397 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 382/382 (100 %) | 2 diff (99.5 %id) | |
BQ005153 | Chondrosarcoma, Left Pelvis | .h-u | 1262 to 1689 | 443 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 428/428 (100 %) | 0 diff (100 %id) | |
CB215435 | normal endometrium, late proliferativephase, cycle day 13, uterus | .a | 990 to 1634 | 1 to 645 | 645/645 (100 %) | 0 diff (100 %id) | |||
BU181063 | large cell carcinoma, lung | .a | 688 to 1519 | 1 to 845 | exact | 845/918 (92 %) | 20 diff (97.9 %id) | ||
BQ421344 | embryonal carcinoma, cell line, testis | .a | 685 to 1758 | 1 to 1078 | exact | 1078/1086 (99 %) | 39 diff (96.5 %id) | ||
BQ430989 | large cell carcinoma, lung | .a | 1061 to 1955 | 1 to 900 | 900/901 (99 %) | 23 diff (97.5 %id) | |||
CA773684 | Pancreas, Purified pancreatic islet | .a | 775 to 1364 | 590 to 1 | exact | 590/590 (100 %) | 0 diff (100 %id) | ||
BQ430228 | epithelioid carcinoma, Pancreas | .a | 1505 to 2368 | 892 to 25 | Submitted on the opposite strand | 868/892 (97 %) | 0 diff (100 %id) | ||
BQ422923 | melanotic melanoma, skin | .c | 168 to 969 | 25 to 839 | E133X K134X L135X S138I L139P ... | 815/842 (96 %) | 28 diff (96.7 %id) | ||
BU838133 | melanotic melanoma, cell line, skin | .a | 700 to 1452 | 1 to 757 | exact | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 757/758 (99 %) | 9 diff (98.9 %id) |
BU168072 | epithelioid carcinoma, Pancreas | .a | 688 to 1561 | 1 to 875 | exact | 875/877 (99 %) | 11 diff (98.8 %id) | ||
BU159325 | epithelioid carcinoma, Pancreas | .a | 675 to 1479 | 810 to 3 | Y16M D17A M18* | Submitted on the opposite strand | 808/882 (91 %) | 20 diff (97.8 %id) | |
BU164813 | eye, retinoblastoma | .a | 656 to 1567 | 1 to 914 | exact | 914/915 (99 %) | 14 diff (98.5 %id) | ||
BU165287 | eye, retinoblastoma | .a | 708 to 1519 | 1 to 816 | exact | 816/875 (93 %) | 9 diff (99.0 %id) | ||
BU173273 | leiomyosarcoma, uterus | .a | 688 to 1583 | 1 to 902 | exact | 902/903 (99 %) | 9 diff (99.1 %id) | ||
BQ719753 | dorsal root ganglia | .a | 696 to 1584 | 1 to 902 | exact | 902/950 (94 %) | 20 diff (97.9 %id) | ||
BQ720851 | sympathetic trunk | .h-u | 1076 to 1689 | 1 to 614 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 614/614 (100 %) | 0 diff (100 %id) | |
BQ723503 | sympathetic trunk | .a | 692 to 1598 | 1 to 910 | exact | 910/910 (100 %) | 5 diff (99.5 %id) | ||
BQ721614 | sympathetic trunk | .h-u | 1447 to 1689 | 1 to 243 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 243/243 (100 %) | 0 diff (100 %id) | |
BQ718926 | sympathetic trunk | .e | 291 to 1047 | 12 to 784 | exact | tiling clone, | 773/884 (87 %) | 24 diff (97.3 %id) | |
BQ892477 | sympathetic trunk | .a | 715 to 1569 | 1 to 865 | exact | 865/865 (100 %) | 23 diff (97.4 %id) | ||
BU844467 | ovary, teratocarcinoma, cell line | .a | 703 to 1451 | 1 to 749 | exact | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 749/749 (100 %) | 0 diff (100 %id) |
BU860831 | mixed (pool of 40 RNAs) | .h-u | 817 to 1619 | 1 to 810 | 810/815 (99 %) | 25 diff (97.0 %id) | |||
CX164737 | human embryonic stem cells differentiated toan early endodermal cell type | .a | 689 to 1491 | 1 to 803 | exact | 803/803 (100 %) | 1 diff (99.9 %id) | ||
CX869030 | embryonic stem | .a | 1439 to 2125 | 713 to 27 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 687/687 (100 %) | 1 diff (99.9 %id) | |
CX869109 | embryonic stem | .a | 664 to 1469 | 1 to 806 | exact | fully sequenced, | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 806/806 (100 %) | 0 diff (100 %id) |
CX782815 | human embryonic stem cells | .a | 1479 to 2131 | 678 to 26 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 653/653 (100 %) | 1 diff (99.9 %id) | |
CX782881 | human embryonic stem cells | .a | 708 to 1509 | 1 to 802 | exact | fully sequenced, | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 802/802 (100 %) | 0 diff (100 %id) |
CX784377 | human embryonic stem cells | .a | 687 to 1488 | 1 to 802 | exact | 802/802 (100 %) | 0 diff (100 %id) | ||
CX788476 | human embryonic stem cells | .a | 684 to 1521 | 1 to 838 | exact | 838/838 (100 %) | 0 diff (100 %id) | ||
CX871240 | embryonic stem | .a | 695 to 1470 | 1 to 776 | exact | 776/776 (100 %) | 0 diff (100 %id) | ||
CX873646 | embryonic stem | .a | 693 to 1578 | 1 to 886 | exact | 886/886 (100 %) | 0 diff (100 %id) | ||
CX760923 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 692 to 1413 | 1 to 715 | exact | Submitted on the opposite strand | 715/729 (98 %) | 10 diff (98.7 %id) | |
CX757418 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 704 to 1409 | 1 to 699 | exact | Submitted on the opposite strand | 699/732 (95 %) | 8 diff (99.0 %id) | |
DR158332 | human embryonic stem cells differentiated toan early endodermal cell type | .a | 708 to 1503 | 1 to 796 | exact | 796/796 (100 %) | 0 diff (100 %id) | ||
DR763040 | embryonic stem | .a | 687 to 1415 | 1 to 730 | exact | 730/730 (100 %) | 1 diff (99.9 %id) | ||
CB962735 | Blood vessels - aorta, basilar and artery | .a | 2224 to 2363 | 1 to 140 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 140/140 (100 %) | 2 diff (98.6 %id) | |
CD108776 | brain, Pituitary | .h-u | 1128 to 1689 | 1 to 562 | 562/563 (99 %) | 1 diff (99.9 %id) | |||
CD246010 | White Matter | .c | 166 to 931 | 1 to 780 | K79X K104Q K110E Q112S G113R ... | AAA | 780/927 (84 %) | 28 diff (97.0 %id) | |
CD172076 | White Matter | .a | 694 to 1549 | 1 to 859 | exact | 859/860 (99 %) | 4 diff (99.6 %id) | ||
CD242783 | brain, Pituitary | .a | 1521 to 2227 | 9 to 721 | 713/885 (80 %) | 7 diff (99.3 %id) | |||
CD300030 | testis | .a | 650 to 1508 | 1 to 862 | exact | 862/862 (100 %) | 6 diff (99.4 %id) | ||
CD518759 | White Matter | .a | 690 to 1555 | 1 to 878 | exact | 878/914 (96 %) | 13 diff (98.6 %id) | ||
CD514814 | White Matter | .a | 629 to 1494 | 1 to 873 | exact | 873/886 (98 %) | 11 diff (98.8 %id) | ||
CD516049 | White Matter | .a | 659 to 1371 | 1 to 715 | exact | 715/911 (78 %) | 3 diff (99.7 %id) | ||
CX163105 | human embryonic stem cells differentiated toan early endodermal cell type | .a | 1493 to 2045 | 579 to 27 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 553/553 (100 %) | 3 diff (99.5 %id) | |
CX163186 | human embryonic stem cells differentiated toan early endodermal cell type | .a | 693 to 1523 | 1 to 831 | exact | fully sequenced, | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 831/831 (100 %) | 0 diff (100 %id) |
DA613267 | .a | 650 to 1224 | 2 to 576 | capped | 575/575 (100 %) | 0 diff (100 %id) | |||
DA616653 | .a | 652 to 1228 | 2 to 578 | capped | 577/577 (100 %) | 0 diff (100 %id) | |||
TI_57220213 | .a | 655 to 1356 | 47 to 746 | exact | 700/746 (93 %) | 7 diff (99.1 %id) | |||
TI_44385059 | .a | 687 to 1465 | 54 to 834 | K78T D79R C80L R81S Y82L ... | 781/781 (100 %) | 4 diff (99.5 %id) | |||
TI_45212757 | .a | 681 to 1408 | 88 to 817 | exact | 730/817 (89 %) | 8 diff (99.1 %id) | |||
TI_45214080 | .a | 670 to 1463 | 134 to 934 | K34N A35G V36C I37H C39L ... | 801/934 (85 %) | 41 diff (95.7 %id) | |||
TI_45214770 | .a | 680 to 1445 | 130 to 899 | V158C A159S F160L E161L G162K ... | 770/899 (85 %) | 15 diff (98.4 %id) | |||
TI_57186231 | .a | 915 to 1645 | 57 to 787 | 731/731 (100 %) | 3 diff (99.6 %id) | ||||
TI_57187355 | .a | 685 to 1434 | 50 to 808 | V5D Q6A V7S A8S D9* | 762/823 (92 %) | 15 diff (98.2 %id) | |||
TI_57187622 | .a | 685 to 1457 | 56 to 829 | exact | 774/774 (100 %) | 7 diff (99.1 %id) | |||
TI_57187677 | .a | 1091 to 1772 | 56 to 737 | 682/682 (100 %) | 3 diff (99.6 %id) | ||||
TI_57190835 | .a | 796 to 1363 | 54 to 630 | 577/795 (72 %) | 16 diff (98.0 %id) | ||||
TI_59392521 | .a | 1500 to 2298 | 91 to 901 | 811/955 (84 %) | 30 diff (96.9 %id) | ||||
TI_59394570 | .a | 864 to 1453 | 87 to 673 | 587/892 (65 %) | 5 diff (99.5 %id) | ||||
TI_59387218 | .a | 689 to 1329 | 103 to 744 | D66G P67S K69Q H70A V72S ... | 642/642 (100 %) | 2 diff (99.7 %id) | |||
TI_59389877 | .a | 667 to 1464 | 103 to 903 | K114N M115N I116D Y117L A118C ... | 801/802 (99 %) | 11 diff (98.7 %id) | |||
N85960 | .a | 710 to 940 | 1 to 226 | 226/226 (100 %) | 8 diff (96.5 %id) | ||||
DA623601 | Kidney | .f | 1 to 550 | 2 to 551 | tiling clone, capped | 550/550 (100 %) | 0 diff (100 %id) | ||
DA624916 | Kidney | .a | 652 to 1203 | 2 to 553 | capped | 552/552 (100 %) | 0 diff (100 %id) | ||
CB113888 | Liver | .h-u | 1120 to 1690 | 1 to 571 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 571/572 (99 %) | 2 diff (99.7 %id) | |
CB109953 | Liver | .h-u | 1038 to 1678 | 1 to 641 | 641/641 (100 %) | 1 diff (99.9 %id) | |||
CB137620 | Liver | .a | 675 to 1305 | 1 to 631 | exact | 631/631 (100 %) | 0 diff (100 %id) | ||
CB148720 | Liver | .a | 837 to 1394 | 1 to 558 | 558/558 (100 %) | 0 diff (100 %id) | |||
CB150243 | Liver | .a | 685 to 1284 | 1 to 600 | exact | 600/600 (100 %) | 0 diff (100 %id) | ||
CB158829 | Liver | .a | 715 to 1338 | 1 to 624 | exact | 624/624 (100 %) | 0 diff (100 %id) | ||
BP289826 | lung | .a | 720 to 1304 | 1 to 585 | exact | 585/585 (100 %) | 0 diff (100 %id) | ||
AU310133 | neuroblastoma | .a | 651 to 1233 | 1 to 583 | 583/583 (100 %) | 0 diff (100 %id) | |||
NM_006870.3 | .a | 520 to 2133 | 1 to 1614 | exact | RefSeq, | 1614/1614 (100 %) | 0 diff (100 %id) | ||
NM_001011546.1 | .c | 1 to 1746 | 1 to 1746 | exact | RefSeq, | 1746/1746 (100 %) | 0 diff (100 %id) | ||
BP307325 | brain | .a | 690 to 1271 | 1 to 582 | 582/582 (100 %) | 0 diff (100 %id) | |||
DC365819 | .a | 511 to 1045 | 1 to 536 | 536/536 (100 %) | 2 diff (99.7 %id) | ||||
CV575071 | cornea, eye | .a | 656 to 1295 | 1 to 640 | exact | 640/640 (100 %) | 0 diff (100 %id) | ||
BP312977 | mammary gland | .c | 130 to 705 | 1 to 577 | 577/583 (98 %) | 9 diff (98.5 %id) | |||
CD722417 | eye, lacrimal gland | .h-u | 1526 to 1690 | 1 to 165 | 165/226 (73 %) | 1 diff (99.6 %id) | |||
DC378101 | Pancreas | .a | 670 to 1497 | 1 to 830 | exact | 830/833 (99 %) | 9 diff (99.0 %id) | ||
DC426429 | Pancreas | .a | 1686 to 2125 | 441 to 1 | 441/441 (100 %) | 1 diff (99.8 %id) | |||
DA843978 | placenta | .a | 650 to 1219 | 2 to 571 | capped | 570/570 (100 %) | 0 diff (100 %id) | ||
DC380981 | placenta | .e | 1 to 557 | 1 to 557 | tiling clone, | 557/557 (100 %) | 1 diff (99.9 %id) | ||
DA850299 | placenta | .a | 686 to 1246 | 2 to 562 | capped | 561/561 (100 %) | 0 diff (100 %id) | ||
DC383585 | Prostate | .b | 444 to 1012 | 1 to 570 | tiling clone, | 570/570 (100 %) | 2 diff (99.7 %id) | ||
BP328026 | prostata | .a | 651 to 1216 | 1 to 566 | 566/566 (100 %) | 0 diff (100 %id) | |||
BM738223 | Ascites, stomach | .h-u | 1070 to 1648 | 1 to 577 | 577/577 (100 %) | 7 diff (98.8 %id) | |||
BM739298 | Ascites, stomach | .h-u | 1093 to 1565 | 1 to 473 | 473/473 (100 %) | 0 diff (100 %id) | |||
BM760993 | Ascites, stomach | .h-u | 1057 to 1674 | 1 to 620 | 620/623 (99 %) | 3 diff (99.6 %id) | |||
BM786868 | stomach | .a | 670 to 1338 | 1 to 669 | exact | 669/669 (100 %) | 1 diff (99.9 %id) | ||
BM840745 | lymph node, stomach | .a | 670 to 803 | 1 to 135 | 135/135 (100 %) | 8 diff (94.1 %id) | |||
S65738 | .a | 703 to 2125 | 1 to 1424 | exact | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 1424/1424 (100 %) | 3 diff (99.8 %id) | |
TI_1948098555 | .a | 777 to 1271 | 128 to 622 | 495/541 (91 %) | 7 diff (98.8 %id) | ||||
TI_1948098692 | .a | 779 to 1271 | 627 to 132 | 496/1420 (34 %) | 5 diff (99.7 %id) | ||||
TI_1948098830 | .a | 777 to 1271 | 618 to 124 | 495/733 (67 %) | 1 diff (99.9 %id) | ||||
TI_1948098954 | .a | 773 to 1271 | 621 to 124 | 498/733 (67 %) | 5 diff (99.4 %id) | ||||
BP333208 | salivary gland | .a | 649 to 1209 | 1 to 561 | 561/563 (99 %) | 1 diff (99.9 %id) | |||
DA921375 | small intestine | .a | 688 to 1245 | 2 to 559 | capped | 558/558 (100 %) | 0 diff (100 %id) | ||
DA921611 | small intestine | .a | 652 to 1221 | 2 to 571 | capped | 570/570 (100 %) | 0 diff (100 %id) | ||
DA922233 | small intestine | .a | 652 to 1212 | 2 to 562 | capped | 561/561 (100 %) | 0 diff (100 %id) | ||
DA924719 | small intestine | .f | 1 to 518 | 2 to 519 | capped | 518/518 (100 %) | 0 diff (100 %id) | ||
BP340874 | stomach mucosa | .a | 670 to 1252 | 1 to 583 | 583/583 (100 %) | 0 diff (100 %id) | |||
BP341002 | stomach mucosa | .a | 678 to 1259 | 1 to 582 | 582/582 (100 %) | 0 diff (100 %id) | |||
BP343379 | stomach mucosa | .a | 675 to 1254 | 1 to 580 | 580/580 (100 %) | 0 diff (100 %id) | |||
DC392140 | stomach | .a | 651 to 1479 | 1 to 832 | exact | 832/832 (100 %) | 7 diff (99.2 %id) | ||
DC426646 | stomach | .a | 1860 to 2367 | 507 to 1 | 507/507 (100 %) | 5 diff (99.1 %id) | |||
DA963741 | stomach | .a | 629 to 1181 | 2 to 554 | capped | 553/553 (100 %) | 0 diff (100 %id) | ||
DC392421 | stomach | .f | 17 to 591 | 1 to 575 | 575/575 (100 %) | 1 diff (99.9 %id) | |||
DA984836 | synovial membrane tissue from rheumatioidarthritis | .a | 652 to 1217 | 2 to 567 | capped | 566/566 (100 %) | 0 diff (100 %id) | ||
DB006866 | cervix, tumor tissue | .a | 650 to 1221 | 2 to 573 | capped | 572/572 (100 %) | 0 diff (100 %id) | ||
DB023860 | testis | .a | 650 to 1208 | 2 to 560 | capped | 559/559 (100 %) | 0 diff (100 %id) | ||
DB025922 | testis | .b | 1 to 556 | 2 to 557 | tiling clone, capped | 556/556 (100 %) | 0 diff (100 %id) | ||
DB336536 | testis | .b | 1463 to 2055 | 593 to 1 | tiling clone, | 593/593 (100 %) | 3 diff (99.5 %id) | ||
DB039187 | testis | .a | 648 to 1227 | 2 to 581 | capped | 580/580 (100 %) | 0 diff (100 %id) | ||
DB043932 | testis | .a | 652 to 1228 | 2 to 578 | capped | 577/577 (100 %) | 0 diff (100 %id) | ||
DB044025 | testis | .a | 653 to 1229 | 2 to 578 | capped | 577/577 (100 %) | 0 diff (100 %id) | ||
DC399604 | testis | .c | 238 to 771 | 1 to 535 | 535/535 (100 %) | 2 diff (99.7 %id) | |||
BP366162 | lung | .a | 716 to 1297 | 1 to 582 | exact | 582/582 (100 %) | 0 diff (100 %id) | ||
TI_149272323 | .a | 928 to 1452 | 622 to 97 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 526/979 (53 %) | 1 diff (99.9 %id) | ||
TI_149273721 | .c | 295 to 970 | 761 to 86 | exact | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 676/965 (70 %) | 2 diff (99.8 %id) | |
TI_149281487 | .a | 873 to 1452 | 656 to 77 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 580/826 (70 %) | 1 diff (99.9 %id) | ||
TI_149282336 | .h-u | 1062 to 1609 | 632 to 85 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 548/1197 (45 %) | 1 diff (100.0 %id) | ||
TI_149294977 | .h-u | 842 to 1689 | 935 to 89 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 847/946 (89 %) | 10 diff (99.0 %id) | ||
TI_149305136 | .h-u | 821 to 1689 | 940 to 86 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 855/924 (92 %) | 31 diff (96.7 %id) | ||
TI_153988321 | .a | 964 to 1348 | 478 to 94 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 385/385 (100 %) | 0 diff (100 %id) | ||
TI_154018494 | .h-u | 982 to 1689 | 802 to 87 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 716/728 (98 %) | 8 diff (99.0 %id) | ||
TI_154039404 | .h-u | 799 to 1614 | 892 to 85 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 808/977 (82 %) | 21 diff (97.9 %id) | ||
TI_154091043 | .a | 1774 to 2369 | 679 to 86 | tiling clone, AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 594/920 (64 %) | 3 diff (99.7 %id) | ||
TI_154092292 | .h-u | 1169 to 1689 | 608 to 87 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 522/905 (57 %) | 1 diff (99.9 %id) | ||
TI_154103931 | .h-u | 893 to 1689 | 883 to 86 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 798/948 (84 %) | 25 diff (97.4 %id) | ||
TI_154123602 | .a | 696 to 1481 | 873 to 89 | A2P V57L L103C W104G A105H ... | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 785/945 (83 %) | 6 diff (99.4 %id) | |
TI_154124924 | .h-u | 760 to 1614 | 926 to 82 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 845/962 (87 %) | 14 diff (98.6 %id) | ||
TI_154172316 | .a | 712 to 1276 | 90 to 659 | E141K L143S S155F I157N V158W ... | 570/1193 (47 %) | 15 diff (98.8 %id) | |||
DB170634 | kidney, tumor tissue | .a | 687 to 1276 | 2 to 591 | exact | capped | 590/590 (100 %) | 0 diff (100 %id) | |
DB172134 | kidney, tumor tissue | .a | 652 to 1235 | 2 to 585 | capped | 584/584 (100 %) | 0 diff (100 %id) | ||
DC413886 | trachea | .a | 475 to 987 | 1 to 513 | 513/513 (100 %) | 2 diff (99.7 %id) | |||
DC414137 | trachea | .a | 469 to 1044 | 1 to 578 | 578/578 (100 %) | 4 diff (99.4 %id) | |||
BP369283 | testis | .h-u | 964 to 1543 | 1 to 580 | 580/580 (100 %) | 0 diff (100 %id) | |||
DC419083 | stomach, tumor tissue | .c | 127 to 662 | 1 to 536 | 536/536 (100 %) | 1 diff (99.9 %id) | |||
DB245852 | uterus, tumor tissue | .a | 671 to 1230 | 2 to 561 | capped | 560/560 (100 %) | 0 diff (100 %id) | ||
BP372297 | umbilical cord | .a | 678 to 1260 | 1 to 583 | 583/583 (100 %) | 0 diff (100 %id) | |||
BP373605 | umbilical cord | .a | 657 to 1239 | 1 to 583 | 583/583 (100 %) | 0 diff (100 %id) | |||
BP373943 | umbilical cord | .c | 132 to 711 | 1 to 581 | 581/581 (100 %) | 2 diff (99.7 %id) | |||
BP374198 | umbilical cord | .a | 670 to 1251 | 1 to 582 | 582/582 (100 %) | 0 diff (100 %id) | |||
BP374551 | umbilical cord | .a | 651 to 1233 | 1 to 583 | 583/583 (100 %) | 0 diff (100 %id) | |||
BP375057 | umbilical cord | .a | 678 to 1260 | 1 to 583 | 583/583 (100 %) | 0 diff (100 %id) | |||
BQ025740 | placenta | .l-u | 1 to 574 | 590 to 17 | exact | tiling clone, AAA | Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) | 574/574 (100 %) | 0 diff (100 %id) |
BM968170 | lung, Primary Lung Epithelial Cells | .c | 297 to 970 | 690 to 17 | exact | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 674/674 (100 %) | 2 diff (99.8 %id) |
BM983770 | lung, Primary Lung Epithelial Cells | .h-u | 1062 to 1609 | 564 to 17 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 548/552 (99 %) | 1 diff (99.9 %id) | |
BU685531 | lung, Primary Lung Epithelial Cells | .h-u | 980 to 1689 | 725 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 710/710 (100 %) | 4 diff (99.5 %id) | |
BM985202 | lung | .h-u | 1019 to 1689 | 687 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 672/672 (100 %) | 1 diff (99.9 %id) | |
BM671175 | eye, optic nerve | .a | 859 to 1452 | 612 to 19 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 594/594 (100 %) | 0 diff (100 %id) | |
BM705952 | eye, lens | .a | 872 to 1461 | 1 to 590 | 590/590 (100 %) | 0 diff (100 %id) | |||
BM668026 | eye, lens | .a | 1686 to 2125 | 455 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 440/440 (100 %) | 0 diff (100 %id) | |
BM696996 | eye, lens | .a | 691 to 1291 | 1 to 601 | exact | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 601/601 (100 %) | 0 diff (100 %id) | |
BQ189232 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 910 to 1117 | 1 to 207 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 207/218 (94 %) | 2 diff (99.1 %id) | |
BU618069 | Bone, Subchondral Bone | .a | 708 to 1357 | 668 to 19 | exact | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 650/650 (100 %) | 0 diff (100 %id) |
CA434535 | lung, Metastatic Chondrosarcoma | .h-u | 1169 to 1689 | 537 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 522/530 (98 %) | 1 diff (99.9 %id) | |
CA434281 | lung, Metastatic Chondrosarcoma | .a | 1793 to 2369 | 593 to 17 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 577/577 (100 %) | 0 diff (100 %id) | |
CA435004 | lung, Metastatic Chondrosarcoma | .h-u | 1088 to 1689 | 617 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 602/602 (100 %) | 6 diff (99.1 %id) | |
CA437583 | lung, Metastatic Chondrosarcoma | .h-u | 1119 to 1689 | 586 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 571/571 (100 %) | 0 diff (100 %id) | |
CA445120 | lung, Metastatic Chondrosarcoma | .h-u | 946 to 1614 | 686 to 19 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 668/668 (100 %) | 1 diff (99.9 %id) | |
CA446118 | Chondrosarcoma, Left Pelvis | .h-u | 1053 to 1689 | 654 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 639/639 (100 %) | 4 diff (99.4 %id) | |
CA412586 | Chondrosarcoma Grade II, Left Pelvis | .h-u | 1525 to 1683 | 183 to 25 | AAA | 159/165 (96 %) | 0 diff (100 %id) | ||
CA415940 | Chondrosarcoma Cell line | .h-u | 865 to 1614 | 766 to 19 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 748/748 (100 %) | 6 diff (99.2 %id) | |
CA310483 | cell lines, Chondrosarcoma | .h-u | 888 to 1609 | 739 to 17 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 723/723 (100 %) | 2 diff (99.8 %id) | |
CA426916 | cell lines, Chondrosarcoma | .h-u | 929 to 1609 | 697 to 17 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 681/681 (100 %) | 2 diff (99.8 %id) | |
CA421716 | Bone, Enchondroma cell line | .h-u | 1168 to 1687 | 540 to 21 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 520/522 (99 %) | 0 diff (100 %id) | |
BU625681 | cell lines, Enchondroma | .h-u | 1045 to 1689 | 663 to 19 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 645/645 (100 %) | 2 diff (99.7 %id) | |
BQ774213 | Bone, Human Chondrosarcoma Cell Line | .h-u | 956 to 1689 | 749 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 734/734 (100 %) | 0 diff (100 %id) | |
BQ774971 | Bone, Human Chondrosarcoma Cell Line | .h-u | 933 to 1689 | 772 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 757/757 (100 %) | 4 diff (99.5 %id) | |
CA419442 | Bone, Human Chondrosarcoma Cell Line | .h-u | 1089 to 1689 | 616 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 601/601 (100 %) | 5 diff (99.2 %id) | |
BQ775307 | Bone, Human Chondrosarcoma Cell Line | .h-u | 972 to 1689 | 733 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 718/718 (100 %) | 6 diff (99.2 %id) | |
BQ775474 | Bone, Human Chondrosarcoma Cell Line | .h-u | 957 to 1689 | 748 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 733/733 (100 %) | 1 diff (99.9 %id) | |
TI_151771570 | .c | 176 to 779 | 90 to 702 | 613/945 (64 %) | 38 diff (96.0 %id) | ||||
TI_151750949 | .h-u | 1022 to 1690 | 820 to 152 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 669/821 (81 %) | 0 diff (100 %id) | ||
DC419653 | uterus | .a | 421 to 985 | 1 to 565 | 565/565 (100 %) | 0 diff (100 %id) | |||
DB250930 | uterus | .f | 420 to 982 | 2 to 564 | D9* | tiling clone, capped | 563/563 (100 %) | 4 diff (99.3 %id) | |
DB251664 | uterus | .g | 1 to 467 | 2 to 467 | tiling clone, capped | 466/466 (100 %) | 1 diff (99.8 %id) | ||
DB257569 | uterus | .a | 652 to 1229 | 2 to 579 | capped | 578/578 (100 %) | 0 diff (100 %id) | ||
DC420587 | uterus | .a | 511 to 1081 | 1 to 571 | 571/571 (100 %) | 0 diff (100 %id) | |||
DB259818 | uterus | .a | 691 to 1264 | 2 to 575 | capped | 574/574 (100 %) | 0 diff (100 %id) | ||
DB261109 | uterus | .a | 651 to 1216 | 2 to 567 | capped | 566/566 (100 %) | 0 diff (100 %id) | ||
DB262236 | uterus | .h-u | 1 to 544 | 2 to 547 | tiling clone, capped | 546/546 (100 %) | 5 diff (99.1 %id) | ||
DB282963 | uterus | .j-u | 395 to 943 | 2 to 550 | tiling clone, capped | 549/549 (100 %) | 1 diff (99.9 %id) | ||
DB291453 | uterus | .j-u | 1 to 590 | 2 to 591 | exact | tiling clone, capped | 590/590 (100 %) | 0 diff (100 %id) | |
BJ998032 | Wilms tumor | .a | 1 to 461 | 1 to 461 | tiling clone, | 461/461 (100 %) | 2 diff (99.6 %id) | ||
BP376798 | uterus | .a | 651 to 1220 | 1 to 570 | 570/570 (100 %) | 0 diff (100 %id) | |||
BP377013 | uterus | .a | 717 to 1298 | 1 to 582 | exact | 582/582 (100 %) | 0 diff (100 %id) | ||
BI011069 | lung_normal | .c | 1 to 1746 | 1 to 1746 | RefSeq, | 1746/1746 (100 %) | 0 diff (100 %id) | ||
BI011072 | lung_normal | .a | 690 to 1271 | 1 to 582 | 582/582 (100 %) | 0 diff (100 %id) | |||
BI011969 | lung_normal | .a | 511 to 1045 | 1 to 536 | 536/536 (100 %) | 2 diff (99.7 %id) | |||
BI011990 | lung_normal | .a | 656 to 1295 | 1 to 640 | 640/640 (100 %) | 0 diff (100 %id) | |||
BI012063 | lung_normal | .a | 656 to 1295 | 1 to 640 | 640/640 (100 %) | 0 diff (100 %id) | |||
BI012069 | lung_normal | .c | 130 to 705 | 1 to 577 | 577/583 (98 %) | 9 diff (98.5 %id) | |||
DA329089 | hippocampus | .h-u | 1526 to 1690 | 1 to 165 | capped | 165/226 (73 %) | 1 diff (99.6 %id) | ||
CK821256 | Pancreas, Purified pancreatic islet | .h-u | 1526 to 1690 | 1 to 165 | Submitted on the opposite strand | 165/226 (73 %) | 1 diff (99.6 %id) | ||
DB259014 | uterus | .a | 670 to 1497 | 1 to 830 | capped | 830/833 (99 %) | 9 diff (99.0 %id) | ||
DB351544 | uterus | .a | 1686 to 2125 | 441 to 1 | 441/441 (100 %) | 1 diff (99.8 %id) | |||
DA843978 | placenta | .a | 650 to 1219 | 2 to 571 | capped | 570/570 (100 %) | 0 diff (100 %id) | ||
DC380981 | placenta | .e | 1 to 557 | 1 to 557 | tiling clone, | 557/557 (100 %) | 1 diff (99.9 %id) | ||
DA850299 | placenta | .a | 686 to 1246 | 2 to 562 | capped | 561/561 (100 %) | 0 diff (100 %id) | ||
DC383585 | Prostate | .b | 444 to 1012 | 1 to 570 | tiling clone, | 570/570 (100 %) | 2 diff (99.7 %id) | ||
BP328026 | prostata | .a | 651 to 1216 | 1 to 566 | 566/566 (100 %) | 0 diff (100 %id) | |||
BM738223 | Ascites, stomach | .h-u | 1070 to 1648 | 1 to 577 | 577/577 (100 %) | 7 diff (98.8 %id) | |||
BM738223 | Ascites, stomach | .h-u | 1070 to 1648 | 1 to 577 | 577/577 (100 %) | 7 diff (98.8 %id) | |||
BM739298 | Ascites, stomach | .h-u | 1093 to 1565 | 1 to 473 | 473/473 (100 %) | 0 diff (100 %id) | |||
BM739298 | Ascites, stomach | .h-u | 1093 to 1565 | 1 to 473 | 473/473 (100 %) | 0 diff (100 %id) | |||
BM760993 | Ascites, stomach | .h-u | 1057 to 1674 | 1 to 620 | 620/623 (99 %) | 3 diff (99.6 %id) | |||
BM760993 | Ascites, stomach | .h-u | 1057 to 1674 | 1 to 620 | 620/623 (99 %) | 3 diff (99.6 %id) | |||
BM786868 | stomach | .a | 670 to 1338 | 1 to 669 | exact | 669/669 (100 %) | 1 diff (99.9 %id) | ||
BM840745 | lymph node, stomach | .a | 670 to 803 | 1 to 135 | 135/135 (100 %) | 8 diff (94.1 %id) | |||
BM840745 | lymph node, stomach | .a | 670 to 803 | 1 to 135 | 135/135 (100 %) | 8 diff (94.1 %id) | |||
S65738 | .a | 703 to 2125 | 1 to 1424 | exact | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 1424/1424 (100 %) | 3 diff (99.8 %id) | |
TI_1948098555 | .a | 777 to 1271 | 128 to 622 | 495/541 (91 %) | 7 diff (98.8 %id) | ||||
TI_1948098692 | .a | 779 to 1271 | 627 to 132 | 496/1420 (34 %) | 5 diff (99.7 %id) | ||||
TI_1948098830 | .a | 777 to 1271 | 618 to 124 | 495/733 (67 %) | 1 diff (99.9 %id) | ||||
TI_1948098954 | .a | 773 to 1271 | 621 to 124 | 498/733 (67 %) | 5 diff (99.4 %id) | ||||
BP333208 | salivary gland | .a | 649 to 1209 | 1 to 561 | 561/563 (99 %) | 1 diff (99.9 %id) | |||
DA921375 | small intestine | .a | 688 to 1245 | 2 to 559 | capped | 558/558 (100 %) | 0 diff (100 %id) | ||
DA921611 | small intestine | .a | 652 to 1221 | 2 to 571 | capped | 570/570 (100 %) | 0 diff (100 %id) | ||
DA922233 | small intestine | .a | 652 to 1212 | 2 to 562 | capped | 561/561 (100 %) | 0 diff (100 %id) | ||
DA924719 | small intestine | .f | 1 to 518 | 2 to 519 | capped | 518/518 (100 %) | 0 diff (100 %id) | ||
BP340874 | stomach mucosa | .a | 670 to 1252 | 1 to 583 | 583/583 (100 %) | 0 diff (100 %id) | |||
BP341002 | stomach mucosa | .a | 678 to 1259 | 1 to 582 | 582/582 (100 %) | 0 diff (100 %id) | |||
BP343379 | stomach mucosa | .a | 675 to 1254 | 1 to 580 | 580/580 (100 %) | 0 diff (100 %id) | |||
DC392140 | stomach | .a | 651 to 1479 | 1 to 832 | exact | 832/832 (100 %) | 7 diff (99.2 %id) | ||
DC426646 | stomach | .a | 1860 to 2367 | 507 to 1 | 507/507 (100 %) | 5 diff (99.1 %id) | |||
DA963741 | stomach | .a | 629 to 1181 | 2 to 554 | capped | 553/553 (100 %) | 0 diff (100 %id) | ||
DC392421 | stomach | .f | 17 to 591 | 1 to 575 | 575/575 (100 %) | 1 diff (99.9 %id) | |||
DA984836 | synovial membrane tissue from rheumatioidarthritis | .a | 652 to 1217 | 2 to 567 | capped | 566/566 (100 %) | 0 diff (100 %id) | ||
DB006866 | cervix, tumor tissue | .a | 650 to 1221 | 2 to 573 | capped | 572/572 (100 %) | 0 diff (100 %id) | ||
DB023860 | testis | .a | 650 to 1208 | 2 to 560 | capped | 559/559 (100 %) | 0 diff (100 %id) | ||
DB025922 | testis | .b | 1 to 556 | 2 to 557 | tiling clone, capped | 556/556 (100 %) | 0 diff (100 %id) | ||
DB336536 | testis | .b | 1463 to 2055 | 593 to 1 | tiling clone, | 593/593 (100 %) | 3 diff (99.5 %id) | ||
DB039187 | testis | .a | 648 to 1227 | 2 to 581 | capped | 580/580 (100 %) | 0 diff (100 %id) | ||
DB043932 | testis | .a | 652 to 1228 | 2 to 578 | capped | 577/577 (100 %) | 0 diff (100 %id) | ||
DB044025 | testis | .a | 653 to 1229 | 2 to 578 | capped | 577/577 (100 %) | 0 diff (100 %id) | ||
DC399604 | testis | .c | 238 to 771 | 1 to 535 | 535/535 (100 %) | 2 diff (99.7 %id) | |||
BP366162 | lung | .a | 716 to 1297 | 1 to 582 | exact | 582/582 (100 %) | 0 diff (100 %id) | ||
TI_149272323 | .a | 928 to 1452 | 622 to 97 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 526/979 (53 %) | 1 diff (99.9 %id) | ||
TI_149273721 | .c | 295 to 970 | 761 to 86 | exact | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 676/965 (70 %) | 2 diff (99.8 %id) | |
TI_149281487 | .a | 873 to 1452 | 656 to 77 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 580/826 (70 %) | 1 diff (99.9 %id) | ||
TI_149282336 | .h-u | 1062 to 1609 | 632 to 85 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 548/1197 (45 %) | 1 diff (100.0 %id) | ||
TI_149294977 | .h-u | 842 to 1689 | 935 to 89 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 847/946 (89 %) | 10 diff (99.0 %id) | ||
TI_149305136 | .h-u | 821 to 1689 | 940 to 86 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 855/924 (92 %) | 31 diff (96.7 %id) | ||
TI_153988321 | .a | 964 to 1348 | 478 to 94 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 385/385 (100 %) | 0 diff (100 %id) | ||
TI_154018494 | .h-u | 982 to 1689 | 802 to 87 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 716/728 (98 %) | 8 diff (99.0 %id) | ||
TI_154039404 | .h-u | 799 to 1614 | 892 to 85 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 808/977 (82 %) | 21 diff (97.9 %id) | ||
TI_154091043 | .a | 1774 to 2369 | 679 to 86 | tiling clone, AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 594/920 (64 %) | 3 diff (99.7 %id) | ||
TI_154092292 | .h-u | 1169 to 1689 | 608 to 87 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 522/905 (57 %) | 1 diff (99.9 %id) | ||
TI_154103931 | .h-u | 893 to 1689 | 883 to 86 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 798/948 (84 %) | 25 diff (97.4 %id) | ||
TI_154123602 | .a | 696 to 1481 | 873 to 89 | A2P V57L L103C W104G A105H ... | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 785/945 (83 %) | 6 diff (99.4 %id) | |
TI_154124924 | .h-u | 760 to 1614 | 926 to 82 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 845/962 (87 %) | 14 diff (98.6 %id) | ||
TI_154172316 | .a | 712 to 1276 | 90 to 659 | E141K L143S S155F I157N V158W ... | 570/1193 (47 %) | 15 diff (98.8 %id) | |||
DB170634 | kidney, tumor tissue | .a | 687 to 1276 | 2 to 591 | exact | capped | 590/590 (100 %) | 0 diff (100 %id) | |
DB172134 | kidney, tumor tissue | .a | 652 to 1235 | 2 to 585 | capped | 584/584 (100 %) | 0 diff (100 %id) | ||
DC413886 | trachea | .a | 475 to 987 | 1 to 513 | 513/513 (100 %) | 2 diff (99.7 %id) | |||
DC414137 | trachea | .a | 469 to 1044 | 1 to 578 | 578/578 (100 %) | 4 diff (99.4 %id) | |||
BP369283 | testis | .h-u | 964 to 1543 | 1 to 580 | 580/580 (100 %) | 0 diff (100 %id) | |||
DC419083 | stomach, tumor tissue | .c | 127 to 662 | 1 to 536 | 536/536 (100 %) | 1 diff (99.9 %id) | |||
DB245852 | uterus, tumor tissue | .a | 671 to 1230 | 2 to 561 | capped | 560/560 (100 %) | 0 diff (100 %id) | ||
BP372297 | umbilical cord | .a | 678 to 1260 | 1 to 583 | 583/583 (100 %) | 0 diff (100 %id) | |||
BP373605 | umbilical cord | .a | 657 to 1239 | 1 to 583 | 583/583 (100 %) | 0 diff (100 %id) | |||
BP373943 | umbilical cord | .c | 132 to 711 | 1 to 581 | 581/581 (100 %) | 2 diff (99.7 %id) | |||
BP374198 | umbilical cord | .a | 670 to 1251 | 1 to 582 | 582/582 (100 %) | 0 diff (100 %id) | |||
BP374551 | umbilical cord | .a | 651 to 1233 | 1 to 583 | 583/583 (100 %) | 0 diff (100 %id) | |||
BP375057 | umbilical cord | .a | 678 to 1260 | 1 to 583 | 583/583 (100 %) | 0 diff (100 %id) | |||
BQ025740 | placenta | .l-u | 1 to 574 | 590 to 17 | exact | tiling clone, AAA | Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) | 574/574 (100 %) | 0 diff (100 %id) |
BM968170 | lung, Primary Lung Epithelial Cells | .c | 297 to 970 | 690 to 17 | exact | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 674/674 (100 %) | 2 diff (99.8 %id) |
BM968170 | lung, Primary Lung Epithelial Cells | .c | 297 to 970 | 690 to 17 | exact | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 674/674 (100 %) | 2 diff (99.8 %id) |
BM983770 | lung, Primary Lung Epithelial Cells | .h-u | 1062 to 1609 | 564 to 17 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 548/552 (99 %) | 1 diff (99.9 %id) | |
BM983770 | lung, Primary Lung Epithelial Cells | .h-u | 1062 to 1609 | 564 to 17 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 548/552 (99 %) | 1 diff (99.9 %id) | |
BU685531 | lung, Primary Lung Epithelial Cells | .h-u | 980 to 1689 | 725 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 710/710 (100 %) | 4 diff (99.5 %id) | |
BU685531 | lung, Primary Lung Epithelial Cells | .h-u | 980 to 1689 | 725 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 710/710 (100 %) | 4 diff (99.5 %id) | |
BM985202 | lung | .h-u | 1019 to 1689 | 687 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 672/672 (100 %) | 1 diff (99.9 %id) | |
BM671175 | eye, optic nerve | .a | 859 to 1452 | 612 to 19 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 594/594 (100 %) | 0 diff (100 %id) | |
BM671175 | eye, optic nerve | .a | 859 to 1452 | 612 to 19 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 594/594 (100 %) | 0 diff (100 %id) | |
BM705952 | eye, lens | .a | 872 to 1461 | 1 to 590 | 590/590 (100 %) | 0 diff (100 %id) | |||
BM705952 | eye, lens | .a | 872 to 1461 | 1 to 590 | 590/590 (100 %) | 0 diff (100 %id) | |||
BM668026 | eye, lens | .a | 1686 to 2125 | 455 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 440/440 (100 %) | 0 diff (100 %id) | |
BM668026 | eye, lens | .a | 1686 to 2125 | 455 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 440/440 (100 %) | 0 diff (100 %id) | |
BM696996 | eye, lens | .a | 691 to 1291 | 1 to 601 | exact | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 601/601 (100 %) | 0 diff (100 %id) | |
BM696996 | eye, lens | .a | 691 to 1291 | 1 to 601 | exact | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 601/601 (100 %) | 0 diff (100 %id) | |
BQ189232 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 910 to 1117 | 1 to 207 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 207/218 (94 %) | 2 diff (99.1 %id) | |
BQ189232 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 910 to 1117 | 1 to 207 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 207/218 (94 %) | 2 diff (99.1 %id) | |
BU618069 | Bone, Subchondral Bone | .a | 708 to 1357 | 668 to 19 | exact | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 650/650 (100 %) | 0 diff (100 %id) |
BU618069 | Bone, Subchondral Bone | .a | 708 to 1357 | 668 to 19 | exact | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 650/650 (100 %) | 0 diff (100 %id) |
CA434535 | lung, Metastatic Chondrosarcoma | .h-u | 1169 to 1689 | 537 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 522/530 (98 %) | 1 diff (99.9 %id) | |
CA434535 | lung, Metastatic Chondrosarcoma | .h-u | 1169 to 1689 | 537 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 522/530 (98 %) | 1 diff (99.9 %id) | |
CA434281 | lung, Metastatic Chondrosarcoma | .a | 1793 to 2369 | 593 to 17 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 577/577 (100 %) | 0 diff (100 %id) | |
CA434281 | lung, Metastatic Chondrosarcoma | .a | 1793 to 2369 | 593 to 17 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 577/577 (100 %) | 0 diff (100 %id) | |
CA435004 | lung, Metastatic Chondrosarcoma | .h-u | 1088 to 1689 | 617 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 602/602 (100 %) | 6 diff (99.1 %id) | |
CA435004 | lung, Metastatic Chondrosarcoma | .h-u | 1088 to 1689 | 617 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 602/602 (100 %) | 6 diff (99.1 %id) | |
CA437583 | lung, Metastatic Chondrosarcoma | .h-u | 1119 to 1689 | 586 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 571/571 (100 %) | 0 diff (100 %id) | |
CA437583 | lung, Metastatic Chondrosarcoma | .h-u | 1119 to 1689 | 586 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 571/571 (100 %) | 0 diff (100 %id) | |
CA445120 | lung, Metastatic Chondrosarcoma | .h-u | 946 to 1614 | 686 to 19 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 668/668 (100 %) | 1 diff (99.9 %id) | |
CA445120 | lung, Metastatic Chondrosarcoma | .h-u | 946 to 1614 | 686 to 19 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 668/668 (100 %) | 1 diff (99.9 %id) | |
CA446118 | Chondrosarcoma, Left Pelvis | .h-u | 1053 to 1689 | 654 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 639/639 (100 %) | 4 diff (99.4 %id) | |
CA446118 | Chondrosarcoma, Left Pelvis | .h-u | 1053 to 1689 | 654 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 639/639 (100 %) | 4 diff (99.4 %id) | |
CA412586 | Chondrosarcoma Grade II, Left Pelvis | .h-u | 1525 to 1683 | 183 to 25 | AAA | 159/165 (96 %) | 0 diff (100 %id) | ||
CA412586 | Chondrosarcoma Grade II, Left Pelvis | .h-u | 1525 to 1683 | 183 to 25 | AAA | 159/165 (96 %) | 0 diff (100 %id) | ||
CA415940 | Chondrosarcoma Cell line | .h-u | 865 to 1614 | 766 to 19 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 748/748 (100 %) | 6 diff (99.2 %id) | |
CA310483 | cell lines, Chondrosarcoma | .h-u | 888 to 1609 | 739 to 17 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 723/723 (100 %) | 2 diff (99.8 %id) | |
CA310483 | cell lines, Chondrosarcoma | .h-u | 888 to 1609 | 739 to 17 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 723/723 (100 %) | 2 diff (99.8 %id) | |
CA426916 | cell lines, Chondrosarcoma | .h-u | 929 to 1609 | 697 to 17 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 681/681 (100 %) | 2 diff (99.8 %id) | |
CA426916 | cell lines, Chondrosarcoma | .h-u | 929 to 1609 | 697 to 17 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 681/681 (100 %) | 2 diff (99.8 %id) | |
CA421716 | Bone, Enchondroma cell line | .h-u | 1168 to 1687 | 540 to 21 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 520/522 (99 %) | 0 diff (100 %id) | |
CA421716 | Bone, Enchondroma cell line | .h-u | 1168 to 1687 | 540 to 21 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 520/522 (99 %) | 0 diff (100 %id) | |
BU625681 | cell lines, Enchondroma | .h-u | 1045 to 1689 | 663 to 19 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 645/645 (100 %) | 2 diff (99.7 %id) | |
BU625681 | cell lines, Enchondroma | .h-u | 1045 to 1689 | 663 to 19 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 645/645 (100 %) | 2 diff (99.7 %id) | |
BQ774213 | Bone, Human Chondrosarcoma Cell Line | .h-u | 956 to 1689 | 749 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 734/734 (100 %) | 0 diff (100 %id) | |
BQ774213 | Bone, Human Chondrosarcoma Cell Line | .h-u | 956 to 1689 | 749 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 734/734 (100 %) | 0 diff (100 %id) | |
BQ774971 | Bone, Human Chondrosarcoma Cell Line | .h-u | 933 to 1689 | 772 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 757/757 (100 %) | 4 diff (99.5 %id) | |
BQ774971 | Bone, Human Chondrosarcoma Cell Line | .h-u | 933 to 1689 | 772 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 757/757 (100 %) | 4 diff (99.5 %id) | |
CA419442 | Bone, Human Chondrosarcoma Cell Line | .h-u | 1089 to 1689 | 616 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 601/601 (100 %) | 5 diff (99.2 %id) | |
CA419442 | Bone, Human Chondrosarcoma Cell Line | .h-u | 1089 to 1689 | 616 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 601/601 (100 %) | 5 diff (99.2 %id) | |
BQ775307 | Bone, Human Chondrosarcoma Cell Line | .h-u | 972 to 1689 | 733 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 718/718 (100 %) | 6 diff (99.2 %id) | |
BQ775307 | Bone, Human Chondrosarcoma Cell Line | .h-u | 972 to 1689 | 733 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 718/718 (100 %) | 6 diff (99.2 %id) | |
BQ775474 | Bone, Human Chondrosarcoma Cell Line | .h-u | 957 to 1689 | 748 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 733/733 (100 %) | 1 diff (99.9 %id) | |
BQ775474 | Bone, Human Chondrosarcoma Cell Line | .h-u | 957 to 1689 | 748 to 16 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 733/733 (100 %) | 1 diff (99.9 %id) | |
TI_151771570 | .c | 176 to 779 | 90 to 702 | 613/945 (64 %) | 38 diff (96.0 %id) | ||||
TI_151750949 | .h-u | 1022 to 1690 | 820 to 152 | AAA | Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) | 669/821 (81 %) | 0 diff (100 %id) | ||
DC419653 | uterus | .a | 421 to 985 | 1 to 565 | 565/565 (100 %) | 0 diff (100 %id) | |||
DB250930 | uterus | .f | 420 to 982 | 2 to 564 | D9* | tiling clone, capped | 563/563 (100 %) | 4 diff (99.3 %id) | |
DB251664 | uterus | .g | 1 to 467 | 2 to 467 | tiling clone, capped | 466/466 (100 %) | 1 diff (99.8 %id) | ||
DB257569 | uterus | .a | 652 to 1229 | 2 to 579 | capped | 578/578 (100 %) | 0 diff (100 %id) | ||
DC420587 | uterus | .a | 511 to 1081 | 1 to 571 | 571/571 (100 %) | 0 diff (100 %id) | |||
DB259818 | uterus | .a | 691 to 1264 | 2 to 575 | capped | 574/574 (100 %) | 0 diff (100 %id) | ||
DB261109 | uterus | .a | 651 to 1216 | 2 to 567 | capped | 566/566 (100 %) | 0 diff (100 %id) | ||
DB262236 | uterus | .h-u | 1 to 544 | 2 to 547 | tiling clone, capped | 546/546 (100 %) | 5 diff (99.1 %id) | ||
DB282963 | uterus | .j-u | 395 to 943 | 2 to 550 | tiling clone, capped | 549/549 (100 %) | 1 diff (99.9 %id) | ||
DB291453 | uterus | .j-u | 1 to 590 | 2 to 591 | exact | tiling clone, capped | 590/590 (100 %) | 0 diff (100 %id) | |
BJ998032 | Wilms tumor | .a | 1 to 461 | 1 to 461 | tiling clone, | 461/461 (100 %) | 2 diff (99.6 %id) | ||
BP376798 | uterus | .a | 651 to 1220 | 1 to 570 | 570/570 (100 %) | 0 diff (100 %id) | |||
BP377013 | uterus | .a | 717 to 1298 | 1 to 582 | exact | 582/582 (100 %) | 0 diff (100 %id) |